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EXECUTIVE SUMMARY 
INTRODUCTION: Off-pump coronary artery bypass grafting (OPCAB) was developed to avoid the 
deleterious effects of CPB. Current literature reveals some peri-operative advantages of OPCAB, with 
few studies detailing these in Africa.   We review our institutional experience with both approaches in 
higher risk patients to determine pre-operative characteristics, short and mid-term outcomes in a 
developing country.   
PATIENTS AND METHODS: A retrospective review of high risk patients undergoing coronary 
bypass surgery by 2 surgeons in the department between January 2001 and December 2007. Fields 
determined include: pre-operative patient characteristics, intra-operative data and post-operative 
variables (intensive care unit (ICU) stay, blood loss, use of blood products, complications, death and 
follow-up).  
RESULTS: Records of 342 patients were reviewed. Of these, 199 had OPCAB and 143 had CABG-
CPB. There were no  significant differences between the 2 groups for age and CAD risk factors, with 
CAD family history commoner in OPCAB patients (p = 0.009). There were no significant differences 
in incidence of co-morbidities, NYHA class, left ventricular ejection fraction (LVEF) and proportion of 
urgent/emergency surgery. The mean number of vessels grafted was 3.31 and 3.45 in OPCAB and 
CABG-CPB groups respectively (p= 0.145).The intra-operative conversion rate from OPCAB to 
CABG-CPB was 2.5%. The mean ICU duration for OPCAB and CABG-CPB patients was 80.7 hours 
and 104.1 hours respectively (p= 0.181). The mean mechanical ventilation duration in OPCAB and 
CABG-CPB patients was 22.3 hours and 38.3 hours respectively (p= 0.091). The mean ICU blood loss 
in OPCAB and CABG-CPB patients was 808.5 mls and 988.2 mls respectively (p=0.0029).Mean red 
cell (RBC) transfusion was 1.72 units and 2.66 units in OPCAB and CABG-CPB patients respectively 
(p=0.03). The CABG-CPB patients had longer post-operative ward stay than OPCAB patients (7.4 
versus 5.5 days, p= 0.01). The peri-operative mortality rate was 3% and 9% in OPCAB and CABG-
CPB patients respectively (p= 0.016). There was no significant difference in major adverse cardiac 
events (MACE) during the follow –up period up to 8 years. 
CONCLUSION: The pre-operative characteristics in both groups were similar. There was less ICU 
blood loss, less usage of blood and shorter hospital stay in the OPCAB group. Peri-operative mortality 
was worse in the CABG-CPB group, and no difference in MACE during follow up. 
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I. LITERATURE REVIEW 
1. INTRODUCTION 
BACKGROUND 
Ischaemic heart disease (IHD) is the world‘s leading cause of mortality accounting for 6.3 million 
deaths in 1990
1
. Ischaemic heart disease (IHD) is the 2
nd
 commonest cause of mortality and the 11
th
 
commonest cause of years of life lost (YLL) amongst South Africans
2
. Although the exact number of 
myocardial infarction(s) amongst South Africans daily is largely unknown, some unpublished data 
suggests 33 people die daily because of a heart attack and 37 people die daily from heart failure in 
South Africa.  
Premature deaths caused by heart and blood vessel diseases in the productive age group (35-64 years) 
are expected to increase by 41% between 2000 and 2030.  This effect on the workforce of the country 
has an enormous negative impact on the economy
3
. 
Coronary artery disease syndromes include; chronic stable angina, unstable angina, myocardial 
infarction, cardiogenic shock and ischaemic cardiomyopathy 
Coronary artery disease (CAD) can be managed with medical therapy or myocardial revascularization: 
coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). The decision to 
treat a patient with either one or both may depend on past experience or information obtained from 
databases. Several studies have shown a better 5 year survival for CABG over medical therapy
4
. 
Myocardial revascularization as we know it today started in the early 20
th
 century with Alexis Carrel 
playing a pioneering role by attempting the first CABG in 1910; he anastomosed the innominate artery 
of one dog to the distal coronary artery of another dog. Other surgeons who made valuable 
contributions to the field of CABG include; Claude Beck, Robertson, Gross, Kolesov, Favaloro, Green, 
Flemma, Kay and Acar
5
. Others like Sabiston have the distinction of being the first to use a human 
autogenous saphenous vein for CABG in 1962. 
The invention of selective coronary angiography by Sones and Shirley in 1959 enabled lesions to be 
targeted and vessels suitable for grafting to be identified. 
The first effective use of the heart/lung machine (cardio-pulmonary bypass, CPB) for correction of a 
cardiac defect was performed in the Mayo Clinic in 1954, although routine use of CPB for IHD did not 
start until the late 1960s. 
The use of CPB is associated with many systemic insults (systemic inflammatory response) and 
deleterious effects including complement activation, multiple organ dysfunction, neurocognitive 
dysfunction and coagulation abnormalities
6
.  The use of cardioplegic arrest of the heart to perform 
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CABG also has negative effects on myocardial contractility despite the major advances in cardioplegic 
solutions and myocardial protection. 
To avoid the deleterious effects of CPB
7
 a resurgence of CABG on a beating heart (also known as ―off-
pump‖ CABG or OPCAB) took place in the mid 1990s (though it was first introduced in 1967 by 
Kolesov).   
Initially, off-pump surgery was restricted to patients with isolated single vessel or double vessel CAD 
and to patients with significant co-morbidities, such as renal failure, calcified aortas or significant 
peripheral and cerebrovascular disease; patients who could derive maximum benefit from avoiding 
CPB
6
. The practice of OPCAB at the outset was also bedeviled by crude instrumentation and limited 
exposure of the lateral, posterior and inferior target coronary vessels. 
As anaesthetic and surgical techniques improved, with associated improvements in techniques of 
retraction and exposure, the proportion of coronary artery surgery done by OPCAB has increased with 
figures of between 20-30% being quoted
6-11
 and has expanded to include more complex coronary 
anatomy than single or double vessel disease. 
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2. SURGICAL ANATOMY
 
The anatomic arrangement of the coronary arteries is important to the cardiac surgeon because he 
surgically treats the consequences of IHD and also avoids trauma to these vessels when gaining access 
to the heart chambers. 
The coronary arteries are the first branches of the aorta. In the usual distribution, 2 of the 3 aortic 
sinuses give origin to the coronary arteries (CA), in particular, the right coronary artery (RCA) and the 
mainstem of the left coronary artery (LCA) which divides into the left anterior descending (LAD) 
artery and the circumflex artery (Cx). This allows designation of the aortic sinuses as right coronary, 
left coronary and non-coronary sinuses. 
Variations in the origin of the coronary arteries are numerous and include; high take-off (origin above 
the sino-tubular junction), both arteries arising from one sinus or a solitary CA. All the above have 
been associated with sudden death episodes. Other variations include; RCA and its infundibular branch 
arising from separate orifices in the right coronary sinus and the LAD and Cx arteries arising separately 
from the left coronary sinus. 
The major branches of RCA and LCA run within the interventricular (LAD and posterior descending 
artery-PDA) and atrio-ventricular grooves (Cx and RCA). The interventricular arteries supply the 
ventricular walls and septa with oblique and perpendicular branches while the RCA and Cx give 
upward branches to the atrial myocardium and downward branches to the ventricular myocardium. 
The RCA runs in the atrio-ventricular groove and gives off the following branches; infundibular, 
anterior (forms the artery to the sino-atrial node in 60% of people), posterior and middle atrial arteries. 
Other RCA branches include; right anterior ventricular artery, infundibular artery, acute marginal 
artery, artery to the atrio-ventricular (AV) node and the PDA. In most cases (90%) the RCA is dominant 
or codominant and gives rise to the AV node artery and the PDA. In the majority, the RCA continues 
beyond the crux and supplies the inferior surface of the left ventricle as the posterolateral branch. 
The left main stem (LMS) artery originates from the left coronary sinus between the pulmonary trunk 
and the left atrial appendage. It is seldom longer than 1cm and branches into the Cx and LAD. The 
LMS may be much shorter than 1 cm with negative consequences in coronary angiography, coronary 
perfusion during aortic valve replacement (AVR) and may be associated with a higher incidence of 
proximal CAD. 
The LAD runs in the interventricular (IV) groove and gives oblique branches to the right (RV) and left 
ventricles (LV). The 1
st
 oblique branch is to the RV infundibulum, its importance seen in LAD 
occlusion when it links up with the RCA counterpart to form the ring of Veiussens. The LV branches 
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are called diagonal arteries and may be multiple (D1, D2, D3), D1 being the most proximal. The LAD 
also gives septal perforating arteries (sometimes up to 6) which run perpendicularly into the muscular 
septum. The most significant septal artery is the 1
st
 which supplies the septum through the groove 
between the subpulmonary infundibulum and the aortic root; it can be damaged during harvesting of 
the pulmonary valve for autograft AVR (Ross Procedure). Beyond D1, the LAD occasionally has an 
intramyocardial course before resurfacing just before the apex. It then crosses the apex to run in the 
posterior IV groove to link up with the PDA. 
The Cx arises from the LMS behind the origin of the pulmonary trunk and passes beneath the left atrial 
appendage to enter the left AV groove. From there, it has a variable course; it may be insignificant only 
supplying the obtuse margin of the LV, especially when the intermediate artery (3
rd
 LMS branch) is 
present. In 10% of people, the Cx runs in the left AV groove and gives branches to the left atrium (LA) 
and obtuse marginal branches to the LV. The Cx marginal branches are numbered according to the take-
off from the Cx with the first being obtuse marginal artery 1 (OM1). The Cx continues to the crux 
where it gives rise to the PDA and the artery to the AV node. In left coronary arterial dominance, it 
supplies part of the diaphragmatic surface of the RV. In mitral valve surgery, the Cx is at risk of damage 
in the AV groove. The Cx gives the artery to the sinus node in 40% of people usually form one of the 
superior atrial branches; sometimes this sinus node artery arises distally from the Cx making it prone to 
surgical injury. 
The PDA is a branch of the RCA in 90% and of the LCA in 10% of individuals. The PDA may arise 
more proximally from the RCA in a minority of people making it more accessible for in-situ right 
internal thoracic artery grafts. It gives perforating arteries to the muscular septum and often forms 
collaterals with perforating branches of the LAD. It usually terminates at the apex where it forms 
connections with the terminal branches of the LAD. 
There can be multiple connections (collaterals) between these arteries especially in the setting of CAD 
of gradual onset and worsening severity. These connections are formed by the following; 
- perforating arteries in the septum 
- terminal branches of LAD and PDA 
- atrial arteries. 
The atrial collateral connection is called the Kugel‘s artery and connects the Cx with anterior or 
posterior portions of the RCA and also gives branches to the bases of the aortic and mitral valves. The 
collateral circulation is more evident and significant in the presence of CAD. 
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3. PATHOLOGY 
The major cause of CAD is atherosclerosis which is defined as a degenerative disease of large and 
medium sized arteries characterized by lipid deposition and fibrosis. It is a process that develops as a 
response of the vessel wall to chronic multi-factorial injury and leads to the formation of 
atherosclerotic plaques (also known as fibrous plaques or atheromas)
 12, 13
. The plaques are regions of 
thickened intima composed of various mixtures of fibrous tissue, foam cells and lipids
14
. 
The risk factors associated with atherosclerosis include reversible factors (smoking, 
hypercholesterolaemia, diabetes, obesity and hypertension) and irreversible factors (age and family 
history) 
There are 3 stages of atheroma formation; 
1) Fatty streaks; these are early lesions that are seen in the coronaries of teenagers. These lesions 
do not breach the endothelial lining and have no clinical effects in themselves. These are linear 
lesions on the arterial lumen which are composed of lipid –filled macrophages and lesser 
number of lipid bearing smooth muscle cells.  
2) Fibrolipid plaques; these contain a mixture of macrophages and smooth muscles which migrate 
into the plaque and are capped by a layer of fibrous tissue. These are seen by 20 years, 
especially in males. In these lesions, the intima is still intact, but raised and the majority have a 
lipid rich, hypocellular or acellular core region. There is evidence that most fibrous plaques are 
derived from pre-existing fatty streaks
15
. 
3) Complex lesions 
Atherosclerotic plaques tend to form near branch points in areas of turbulent flow involving high and 
low shear stress and also in areas of vessel bifurcation, post-stenotic areas and areas denuded of 
endothelium. The flow patterns in these areas promote endothelial dysfunction and encourage increased 
endothelial contact with platelets and monocytes
16
. 
The regions most prone to atherosclerosis in the coronary artery system include; 
- proximal LAD 
- proximal and distal RCA 
Established atherosclerosis involves all 3 layers of the arterial wall with intimal thickening and fibrosis, 
medial degeneration and lymphocytic infiltration of the adventitia. 
Atherosclerosis leads to remodeling of the vessel wall as the fibrous plaque enlarges. Initially, the 
vessel wall dilates in a way that the luminal diameter is maintained, probably because of physiological 
regulation of lumen diameter in response to blood velocity and shear rate
4
. However, once the limit of 
14 
 
this adaptive mechanism is reached, luminal narrowing occurs; when the collagen filled lesion has 
extended circumferentially round the artery leaving very little normal wall to respond to blood flow. 
About 50% decrease in luminal diameter, that is 75% luminal area, must occur before blood flow is 
affected. 
       An acute ischaemic event is caused by acute changes in the atherosclerotic plaques. Those plaques 
most prone to these changes are the atheromatous types with thin fibrous capsules and large cores of 
lipid rich debris. These changes which may appear as erosions, fissures, ulcers or frank rupture often 
contribute to thrombus formation. Disruption of the plaque surface by mechanisms which include 
haemodynamic trauma and activation of attached platelets and blood cells predisposes to the formation 
of intraluminal and intramural thrombi. The pathogenetic sequence of plaque rupture starts with 
endothelial injury followed by an influx of blood and an increase in intra-plaque pressure leading to 
subsequent fibrous capsule rupture outwards
6
. Plaque rupture leads to vessel wall damage which 
stimulates initiation of 2 pathways toward coagulation; the first, intrinsic pathway of the clotting 
cascade results in thrombin production, while the second pathway involves platelet activation via 
collagen and von Willebrand factor. These platelets subsequently release vasoactive substances and 
platelet aggregation factors like thromboxane and adenosine diphosphate which activate more platelets. 
Fibrinogen in the bloodstream cross-links with platelets via the GP IIB/IIIA receptors and ultimately a 
clot is formed. The degree of myocardial damage depends on the distribution of myocardium supplied 
by the artery affected; the degree of obstruction by the clot, amount of small vessel inflammation, 
thrombotic emboli, vasoconstriction and the extent of collateral flow. 
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4. INDICATIONS FOR CABG
17 
 
Coronary artery bypass grafting (CABG) is indicated if PCI is not feasible (tight left main stem 
disease, diffuse multivessel disease, or calcified coronaries) or is unsuccessful (inability to cross the 
lesion, in-stent stenosis). 
The following are the indications for surgery (CABG);  
1) Patient has refractory angina or large amount of myocardium in ischaemic jeopardy 
- NYHA Class III-IV chronic stable angina refractory to medical treatment 
- Unstable angina refractory to medical treatment 
- Acute ischaemia or haemodynamic instability following attempted coronary stenting or 
angioplasty 
- Acute evolving infarction within 6 hours of onset of chest pain or later if there is evidence 
of ongoing ischaemia (early post-infarction ischaemia). 
- Markedly posistive stress test prior to major intra-abdominal or vascular surgery. 
- Ischaemic pulmonary oedema. 
2) Patients without disabling angina or refractory ischaemia in whom the extent of coronary 
disease, the status of ventricular function, and the degree of inducible ischaemia on stress test 
are such that surgery may improve long-term survival. 
- Left main stem stenosis > 50% 
- Three-vessel disease with ejection fraction (EF) < 50% 
- Three-vessel disease with EF > 50% and significant inducible ischaemia 
- Two-vessel disease with involvement of proximal LAD 
- One- and two-vessel disease with extensive myocardium in jeopardy, but lesions not 
amenable to PCI. 
3) Patients who have indications for other open heart procedures and have coronary artery disease. 
- Valvular operations, septal myectomy. 
- Concomitant surgery for post-infarction mechanical defects (left ventricular aneurysm, 
ventricular septal rupture, acute mitral regurgitation). 
- Coronary artery anomalies with risk of sudden death e.g vessel passing between the aorta 
and pulmonary artery. 
-  
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5. INDICATIONS FOR OPCAB 
The reason behind the resurgence of OPCAB was and is to avoid the negative effects of CPB which are 
multi-systemic and include; 
- Coagulation disorders18; These are because of haemodilution from the pump priming solution, 
platelet degranulation, hyperfibrinolysis and consumption of the coagulation factors. 
- Systemic inflammatory response18; This is from induction of complement activation, endotoxin 
release, leucocyte activation, expression of adhesion molecules and the release of inflammatory 
mediators like oxygen free radicals, arachidonic acid metabolites, cytokines, platelet activating 
factor, nitric oxide and endothelins. 
These disorders may increase post-operative complications which include respiratory failure, renal 
failure, multi-systemic organ failure, neurologic dysfunction and bleeding problems
18
. 
This technique is indicated
6, 7, 18-21
 in patients who will derive the maximum benefit from avoidance 
of CPB. These include those with; 
1) Porcelain aorta and severe atherosclerotic and partially calcified aorta, in whom ascending aorta 
canulation, aortic cross-clamping and application of the side-biting clamp would be extremely 
difficult or dangerous with consequent strokes and neurologic dysfunction from atheromatous 
and calcific emboli. 
2) Poor left ventricular function(left ventricular ejection fraction ≤ 35 %); OPCAB in this situation 
avoids the myocardial ischaemia and depression from CPB and studies have shown lower 
morbidity and mortality in this group when compare to those who had CABG-CPB. 
3) High risk subgroups; this include those with advanced age, renal dysfunction, pulmonary 
dysfunction (chronic obstructive pulmonary disease), diabetes mellitus and obesity. They all 
benefit from avoidance of CPB and its deleterious effects. 
It must however be stated that as surgical skills, confidence and techniques of OPCAB have 
improved with time, the indications and patient subgroups in whom OPCAB is performed have 
increased.  
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6. CONTRA-INDICATIONS FOR OPCAB 
The group of patients in which OPCAB would be inappropriate
6, 18, 20
 and is contra-indicated 
include; the absolute contra-indications: 
1) Cardiogenic shock 
2) Ischaemic arrhythmias 
3) Thoracic anatomy precluding  adequate rotation of the heart, for example; severe pectus 
excavatum, previous left pneumonectomy 
The relative contra-indications include; 
1) Intramyocardial coronary arteries 
2) Unusually small or calcified coronary arteries 
3) If endarterectomy is required 
4) If concomitant cardiac surgery is required, for example, mitral valve repair or aortic valve 
replacement. 
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7. OPERATIVE MANAGEMENT OF OPCAB PATIENTS
19 
The introduction of OPCAB technique in the operating room raises some patient care issues for all 
concerned; surgeon, nursing staff and anaesthetists and requires adequate communication between 
them to ensure patient safety. 
This is because an OPCAB case may encounter expected or unexpected changes in haemodynamics, 
sequence of grafting of the coronary arteries and operative plan and all have to be ready to adjust to 
these changes to ensure patient safety and operative success. 
Anaesthetic Management 
All patients for OPCAB are done under general anaesthesia with induction (opiods, benzodiazepines), 
muscle relaxants (nondepolarizing agents) and maintenance of anaesthesia (isoflurane, propofol) 
6, 11, 20-
24
. 
Non–invasive monitoring of electrocardiogram (ECG) and pulse oximetry is mandatory11, 21, 23, 24 
All patients require invasive monitoring
11, 21, 23-25
 which include; 
- Arterial line 
- Central venous line 
- ± Swan Ganz catheter; Usually for those with significant left ventricular depression and for 
monitoring of the pulmonary artery pressure which elevation is usually the first sign of 
haemodynamic compromise prior to arrhythmias and cardiovascular collapse. 
Heparin is given intravenously (1-1.5mg/kg) to achieve a target activated clotting time (ACT) of > 300-
350 seconds
6,10,11,21,22
 and this re-dosed as needed to maintain this level during the operation. 
The maintenance of normothermia
21, 25, 26
 during OPCAB is important because the rewarming seen in 
CABG-CPB from CPB is absent. This avoids the negative consequences of hypothermia which include 
bleeding post-operatively, arrhythmias and post-operative complications. The patient is kept warm pre-
operatively by warming the induction room, warm blankets and warmed intravenous fluids. Intra-
operatively, a convective forced air warming system (Bair Hugger) is also used.  
Maintenance of haemodynamic stability
11, 24
 is also important especially during lifting and retraction of 
the heart for exposure of the target coronary vessels. These positional changes may be accompanied by 
reductions in preload and left ventricular filling due to kinking of the vena cave, the pulmonary veins 
and the right ventricular outflow tract leading to poor cardiac output. The first line treatment for 
haemodynamic instability is administration of IV fluids. Other manouevres involve changing the 
patient‘s position to alter the patient‘s preload status to cater for different haemodynamic states. For 
example, during rightward heart displacement, the Trendelenburg position improves preload while 
19 
 
during the application of the partial occlusion aortic clamps, the reverse Trendelenbug position 
decreases preload. Another measure to maintain haemodynamic stability includes the use of inotropes 
(adrenaline, dobutamine, dopamine) and vasopressors 
10, 26, 27
 (phenylephrine, ephedrine, 
noradrenaline). Use of inotropes and vasopressors limits the use of intravenous fluids and positions the 
patient for a more favourable post-operative period in terms of rate of complications. 
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8. INTRA-OPERATIVE MANAGEMENT 
The operation starts with routine draping for median sternotomy
6, 9-11, 24
.  Access to the chest is through 
a median sternotomy, but can also be through a thoracotomy. The left and/or right internal mammary 
arteries (LIMA/RIMA) 
10, 21
 are then harvested if planned for use and with simultaneous harvesting of 
the saphenous vein or radial artery if needed by open or endoscopic means
6, 11, 21
. It is important the 
divide the diaphragmatic muscle slips under the xiphoid process to allow elevation of the sternal 
border. The pleural space on the side of the ITA being harvested may or may not be opened
23
. 
Heparin is given intravenously (1-1.5mg/kg) to achieve a target activated clotting time (ACT) of > 300-
350 seconds
6,10,11 ,21,
 
22
and this re-dosed as needed to maintain this level during the operation. 
After heparinization, the IMA is divided and papaverine ± lidocaine is injected extraluminally or 
intraluminally.  
A sternal retractor designed to act as a platform for the stabilizers and positioners for OPCAB are 
placed in the chest.  
A wide inverted T shaped pericardiotomy
 19, 24
 is done, dividing the pericardium along the diaphragm 
towards the right and left phrenic nerves. This facilitates cardiac displacement during the operation. 
Pericardial traction sutures
9, 10
 are then inserted on the left, right and oblique sinus (two-thirds of the 
way between the inferior vena cava and left pulmonary vein); so called ‗Lima‘ stitches. Alternatively, 
some cotton slings
6, 24
 (e.g. vaginal swab) are applied at the base of the deep posterior pericardial 
suture. All these sutures and cotton slings are for rotation and elevation of the heart for adequate 
coronary target vessel exposure. 
The ascending aorta is now assessed for atherosclerosis
21
 to enable optimal application of the partial 
occlusion clamps for graft anastomosis. This is done using the epi-aortic ultrasound (most sensitive 
method), trans-oesophageal echocardiography or digitally. In the absence of diffuse atherosclerosis, the 
anastomosis proceeds in the normal fashion, but in its presence, other options would include using an 
anastomotic device
6
 or different proximal sources of blood flow; for example, the brachiocephalic 
artery, LIMA, RIMA or subclavian artery. 
The heart is now positioned to commence graft anastomosis using the pericardial sutures and the 
cardiac stabilizing ± positioning devices
6, 9, 10, 21, 23, 24, 28, 29
, the position of these devices can be changed 
depending on the target vessel. At the OPCAB advent, compression devices were used, but more 
recently suction type devices such as the Octopus are now used; stabilization is achieved at the 
mechanical median of the cardiac cycle and is maintained while mechanical interference with 
ventricular function is minimized. The suction positioning device attaches to the epicardial surface and 
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elevates and displaces the heart to provide exposure of the target vessels. A suction coronary 
stabilization device is also used to facilitate exposure and may be applied anywhere on the epicardial 
surface.  
The sequence of grafting of the target vessels is important to avoid myocardial ischaemia and ensure 
haemodynamic stability. The graft sequence should also be individualized depending on the anatomic 
patterns of coronary disease, collateralization, myocardial contractility, ascending aortic 
atherosclerosis, conduit availability and graft geometry. The principles include; grafting the 
collateralized vessel first and reperfusion with proximal anastomoses or IMA anastomoses; grafting the 
collateralizing vessel last to avoid interruption of blood flow from the collateralizing to the 
collateralized vessel until after the collateralized vessel has been grafted; the proximal anastomoses 
may be performed first
6
 to aid in early reperfusion of a critical collateralized vessel (a drawback is 
difficulty in estimation of graft length after proximal anastomosis); the LIMA- LAD anastomosis is 
done first if there is tight left main stenosis of if the LAD is collateralized
6,10,21
. 
After optimal exposure, the target vessel is occluded proximally with silastic vessel loops or soft 
vascular clamps
6
; this may be accompanied by test occlusion of the target vessel if it is poorly 
collateralized to determine the effect of regional myocardial ischaemia when anastomosis commences. 
The target vessel is opened with a coronary knife and the arteriotomy is extended with coronary (Potts) 
scissors. At this juncture, a coronary shunt may be used. A bloodless field is achieved by dispersal of 
retrograde bleeding from the target vessel with a humidified CO2 blower
6
; excellent visualization is 
necessary for a precise anastomosis. Distal anastomosis is done with 7/0 or 8/0 continuous 
polypropylene. The proximal anastomosis is done with application of a partial occlusion clamp after 
the systolic blood pressure has been reduced to < 95mmHg; proximal aortotomies are made with a 
4mm aortic punch and vein grafts and arterial graft anastomoses are then made with 6/0 and 7/0 
continuously polypropylene sutures respectively. The aortic root is de-aired through the most anterior 
anastomosis after the partial occlusion clamp is removed before tying the suture. The vein grafts are de-
aired with a 25 gauge needle. 
After completion and reperfusion of all the grafts, protamine is given to partially correct the ACT
22
. 
Haemostasis is maintained and chest tubes are inserted into the mediastinal, pericardial and open 
pleural spaces. Temporary epicardial pacing wires are inserted. The chest is closed in the standard 
fashion with sternal wires, continuous absorbable stitches for the subcutaneous tissue and absorbable 
suture or nonabsorbable suture/staples for the skin 
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MYOCARDIAL PROTECTION DURING OPCAB 
Myocardial protection during OPCAB is necessary because occlusion of the target vessels during 
anastomosis has several negative consequences including; regional ischaemia, myocardial injury, target 
vessel endothelial injury and apoptosis that contributes to post-operative pathology. 
In the initial experiences with OPCAB, intermittent pharmacologic arrest and bradycardia were 
induced with adenosine and short acting beta-blockers. The mechanism of action was reduction of 
myocardial motion and myocardial oxygen demand. This method has largely being superceded by the 
use of the current suction stabilizers. 
Ischaemic pre-conditioning has also being used for myocardial protection. This involves a brief 
occlusion and reperfusion of the target vessel (2-5 minutes) before the long occlusion period necessary 
to construct a coronary anastomosis and this is thought to improve myocardial protection in the area 
served by the occluded target vessel. More recent studies on ischaemic preconditioning suggest that 
any ischaemia is protective. 
Maintenance of an adequate systemic blood pressure by optimization of preload and vasopressors is 
important for perfusion of the coronary arteries and its collaterals. This is especially important during 
target vessel occlusion. 
The optimization of the pericardial sutures, cardiac positioning and stabilization devices may also 
protect the myocardium by achieving adequate exposure without compression of the cardiac chambers 
and with unwanted haemodynamic compromise or arrhythmias. 
Optimization of the sequence of grafting to reduce myocardial ischemia is also another strategy. 
An intracoronary shunt
6, 10,21,24,29
 may be inserted selectively or electively. It is useful if significant 
haemodynamic compromise occurs after target vessel occlusion. It is also useful electively with large 
right coronary arteries, brady-arrhythmias and intramyocardial vessels where occlusion of the vessel 
will be dangerous. The shunt when appropriately sized (range between 1-3 mm), is easily placed and 
provides significant blood flow and a bloodless field. The shunt is removed and the coronary artery is 
de-aired prior to tying the suture on the distal anastomosis and flow is re-established. 
The use of intra-aortic balloon pump (IABP)
 10
 improves haemodynamic stability especially during 
exposure and occlusion of the target vessels. Generally, the indication for IABP is similar to the 
indication for any patient having CABG. 
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9. POST-OPERATIVE MANAGEMENT 
The post-operative management of OPCAB patients does not differ significantly from that of CPB-
CABG patients; cardiac, respiratory, renal function and chest tube drainage monitoring procedures are 
very similar. However, there are some differences in the post-operative management of CABG-CPB 
and OPCAB patients. 
Patients who have had OPCAB have a reduced need for inotropes post-operatively because of reduced 
myocardial stunning and ischaemia. 
Patients also have a reduced need for IV fluids because they are most likely euvolaemic intra-
operatively and have avoided the systemic inflammatory response and capillary leak associated with 
CPB. Instead, low dose vasopressors and careful IV fluid usage is advocated. 
They also have a reduced haemorrhage and blood transfusion requirements because of avoidance of 
CPB. Therefore persistent post-operative haemorrhage is more likely from a surgical cause than 
coagulation factor deficiency or platelet dysfunction. 
Post OPCAB patients are also in a hypercoagulable state making them prone to graft thrombosis. This 
can be counteracted by commencing aspirin on the day of operation and some authorities also 
commence clopidogrel. 
They also have a reduced need for mechanical ventilation and are sometimes extubated in the operating 
room or in a high care unit, easily after surgery (‗fast tracking‘). 
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10. OUTCOME MEASURES: OFF PUMP CORONARY BYPASS GRAFTING 
VERSUS CORONARY ARTERY BYPASS GRAFTING WITH 
CARDIOPULMONARY BYPASS 
PRE-OPERATIVE FACTORS 
The literature is replete with studies that have compared the presence of pre-operative CAD risk factors 
in both OPCAB and CABG-CPB patients. 
Most studies showed no significant difference in the ages (range, median, mean) at which both groups 
were operated on, with most of the patients in both groups being in the 7
th
 decade of life
 8,20,29-31
 while 
some studies showed some differences
7,22 
Most studies showed a male preponderance (51-95%)
 8, 21, 22, 25, 27, 29, 30, 32 
in both groups without any 
significant intergroup differences, while some showed a female preponderance in the OPCAB group
6,7
. 
The female gender has been known to be associated with increased resource utilization (prolonged 
intubation times and hospital stay) in OPCAB patients
11, 33
. 
There is no significant difference in the incidence of obesity in both OPCAB and CABG-CPB patients 
with figures of 6.3- 18.9% and 2.3- 20.4% in OPCAB and CABG-CPB patients respectively, though 
some studies revealed significantly more obesity among male patients who had OPCAB
11, 33
.  
The incidence of hypertension in both groups ranges between 68-87.5%and 47-69% in OPCAB and 
CABG-CPB patients respectively without any significant inter group difference
18, 30, 34-36
. 
Many studies showed no intergroup difference in the incidence of prior pre-operative myocardial 
infarction with figures of 27.5-50% and 25-43.3% being quoted for OPCAB and CABG-CPB patients‘ 
respectively
6, 9, 10, 29
.  
A review of the incidence of diabetes mellitus (DM) among OPCAB patients showed rates ranging 
between 10-64.4% and in CABG-CPB patients rates of 20-61.6%, but there was no significant 
intergroup differences
8, 21, 32, 34
.  
There are conflicting figures of the incidence of chronic obstructive pulmonary disease (COPD) among 
OPCAB and CABG-CPB patients with some quoting significantly higher rates in either the OPCAB or 
CABG-CPB group. Figures quoted have been between 5.7-14% and 0.9-30% for the OPCAB and 
CABG-CPB groups‘ respectively 6, 7, 9, 28, 32, 35. 
Renal dysfunction is a major predictor of in-hospital and late mortality post CABG. The incidence of 
renal dysfunction in OPCAB and CABG-CPB 3.06%
40
 4.9%
57
patients ranges between 4.1-4.5% and 3-
4.9% respectively
7, 18, 25
. The causes of renal failure in CABG patients include; DM, hypertension, 
atherosclerosis and glomerulonephritis
30
. 
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Preoperative cerebro-vascular accident (CVA) incidence in both groups of patients ranges between 2.7-
15.3% and 2.7-15% in OPCAB and CABG-CPB patients respectively, but with most studies showing 
no significant intergroup differences and some showing a significantly higher incidence in CABG-CPB 
patients 
6,7,9,32,34,35
.  
The history of past or current smoking is present in 27-66% of OPCAB patients and 27-59% of CABG-
CPB patients with no intergroup differences
7, 9,10,27,29
. 
The incidence of hypercholesterolaemia in OPCAB and CABG-CPB patients ranges between 31.8-
73% and 24-77.5% respectively and without significant differences between them 
7,9,21,23,27,34,36
. 
Peripheral vascular disease (PVD) is seen in 5.7-22.7% of   OPCAB patients and 4.1-19% of CABG-
CPB patients, but there is no significant difference between the 2 groups
7, 9, 23,25,28,30
. 
Carotid artery stenosis associated with CAD is seen in 45.5% of OPCAB and 57.1% of CABG-CPB 
patients
23
.  
Family history of CAD as a CAD risk factor is reported in 25-60% of OPCAB patients and 14.6-57.2% 
of CABG-CPB patients 
7,27,29,30
 with some showing a significantly higher rate in CABG-CPB patients
7
.  
One study showed a significantly higher rate of pre-operative aspirin usage in OPCAB patients (71%) 
compared to CABG-CPB patients (64%). There was also a significantly higher rate of clopidogrel use 
in OPCAB patients (11.8%) when compared to CABG-CPB patients (4.6%)
 18
. Another study showed 
no difference in pre-operative aspirin use for OPCAB (56.8%) and CABG-CPB (53.7%) patients
10
. 
The incidence of pre-operative arrhythmia was found in one study to be 9% and 11% in OPCAB and 
CABG-CPB patients respectively
34
 while another study showed the incidence of atrial fibrillation 
among CABG-CPB to be 3.4%
30
. 
The distribution of the patients into Canadian Cardiovascular Society (CCS) classes for angina severity 
for OPCAB and CABG-CPB patients respectively are for CCS I; 15-25% and 7-18% , CCS II; 12-50% 
and 16.7-58%, CCS III; 22.5-54.6% and 17.5-69.2% and finally CCS IV; 2.5-74.3% and 2.5-38.6% 
respectively
8-10,28,34
 .Mean CCS class for OPCAB and CABG-CPB is  3.5±0.7 and 3.25±0.63 
respectively
29
. There were no significant intergroup differences.  
The distribution of the patients into New York Heart Association (NYHA) classes for degree of cardiac 
decompensation and dyspnoea for OPCAB and CABG-CPB patients respectively are NYHA I; 4% and 
9%, NYHA II; 26% and 37%, NYHA III; 13.6-53% and 8-43% and finally NYHA IV; 17% and 10 % 
respectively
10,34
. The mean NYHA class for OPCAB and CABG-CPB patients is 3.00 ± 0.27 and 2.94 
± 0.13 respectively
10
. Another study by Reeve and Ascione et al showed the OPCAB and CABG-CPB 
patients in NYHA class > 2 to be 27.3% and 33.4% respectively
35
. There were no significant intergroup 
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differences. 
The mean left ventricular ejection fraction (LVEF) quoted for OPCAB (47.1 ± 2.34
10 
47.2 ± 9.69
25
, 
46.9 ± 14.9
32
) and CABG-CPB (48.7 ± 0.58
10, 
46.8 ± 12.7
32
) patients are similar and without significant 
intergroup differences. Severe LV dysfunction (LVEF < 25%) was present in 2.6-7% of OPCAB 
patients and 3.7% of CABG-CPB patients
27, 35
. 
Pre-operative intra-aortic balloon pump (IABP) use in OPCAB and CABG-CPB patients ranges from 
2-25.7% and 1-14.8% respectively
6, 7, 9, 10, 34
 with most not showing any significant differences and one 
study showing a higher rate of pre-operative IABP use in CABG-CPB patients
7
. The indications for 
pre-operative IABP use include; left main stenosis (> 75%), intractable resting pain, left ventricular 
dysfunction (EF < 35%), recent acute MI and unstable angina
26
. Pre-operative IABP could lead to pre-
operative reduction in myocardial ischaemia, avoidance of progressive cardiac dysfunction, 
minimization of low flow episodes and therefore allow for safer induction of general anaesthesia and 
improve surgical risk in high-risk patients
26
. 
The incidence of previous pre-operative cardiological intervention (stents/angioplasty) in OPCAB and 
CABG-CPB patients is between 7-25.6% and 10-35.5% respectively and no intergroup differences seen 
9,10,34
. 
Many studies showed a previous cardiac operation (CABG) being done in 2.3-6.8% of OPCAB and 
3.7-8.0% of CABG-CPB patients and without any significant intergroup differences present
7, 10, 17, 32 34, 
35
.  
The proportion of the operations done as emergency, urgent or elective procedures for OPCAB patients 
are between 4-37.1%, 58.7-65.4% and 20-72.5% respectively while that for CABG-CPB patients range 
between 6.9-7.7%, 55-71.4% and 25.8-62.7% respectively
9,18,27,30,34,35,37
.Some studies showed a 
significantly higher proportion of emergency cases in CABG-CPB patients
37
. 
Unstable angina as an indication for surgery in both groups was seen in 18-74.3% and 13.7-55.7% of 
OPCAB and CABG-CPB patients respectively with no significant intergroup difference between the 2 
groups
9, 27, 30, 32, 38
. 
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INTRA-OPERATIVE FACTORS 
 Conversion from OPCAB to CABG-CPB intra-operatively occurs occasionally for several reasons 
which include; anatomic (failure of adequate exposure of target vessel, deep intra-myocardial course of 
target vessel, small vessels, adhesions or an enlarged heart), haemodynamic instability upon 
manipulation of the heart( hypotension, mitral and/or aortic regurgitation, bleeding, acute ischaemia as 
detected by ST segment or wall motion changes, left ventricular dysfunction) and electrical 
disturbances during the procedure (ventricular fibrillation, ventricular tachycardia, heart block or 
severe bradycardia)
39
. A significant proportion of patients are converted during grafting of the obtuse 
marginal vessels or the ramus intermedius
25
. The consequence of intra-operative conversion is 
increased peri-operative mortality which may be up to 6-12 fold more than in the unconverted group
39, 
40
. The conversion rate quoted in literature ranges between 0-8.8 % 
21, 25, 26, 35, 38-41
. 
The cell saver which salvages mediastinal blood for autologous transfusion is used in both OPCAB and 
CABG-CPB patients, but the quantity of salvaged blood is significantly higher in CABG-CPB patients. 
It also leads to less homologous blood transfusion in both groups, but significantly less so in OPCAB 
patients
8
. 
The mean duration of cardiopulmonary bypass and aortic cross-clamp (ischaemic) time among CABG-
CPB patients range between 56-108 minutes and 35.8-97 minutes respectively
6,21-23,30,41
.  
The mean number of grafts at the advent of OPCAB was significantly less than that for CABG-CPB, 
but with the passage of time and increased experience with the technique, more recent studies report 
very similar numbers. Some studies have quoted figures between 2.1-3.5 and 2.9-3.9 grafts for OPCAB 
and CABG-CPB patients respectively with most being significantly less in OPCAB 
patients
6,10,25,27,28,30,32,34,38,41
 and some not showing any significant difference between the 2 groups
41
. 
Reasons given for these include the greater technical challenge of doing OPCAB on a beating heart as 
compared to a still heart as obtained in CABG-CPB and greater associated haemodynamic instability 
from cardiac manipulation. 
The left IMA is used in 34-100% and 31-98.2% of OPCAB and CABG-CPB patients with most studies 
showing no significant difference between the groups
9, 10, 38, 41
, some showing significantly more use in 
OPCAB patients
6, 21
 and others showing more usage in CABG-CPB patients
28
. The rate of right IMA 
use varies between 11-31.4% and 16-37.7% of OPCAB and CABG-CPB patients
25, 38, 41
. The use of 
bilateral IMA is avoided in diabetes patients due to the increased risk of post-operative sternal wound 
infection. The rate of radial artery use varies between 17.4-71.4% and 42-58.7% of OPCAB and 
CABG-CPB patients respectively in published series
6, 9, 25, 41
 with no significant intergroup differences. 
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The rate of greater saphenous vein graft use in both groups is between 8-77% in both groups
9, 25, 38, 41
. 
Gastro-epiploic artery graft is used in 8-26.6% and 3-28.9% of OPCAB and CABG-CPB patients 
respectively
38, 41
. 
Total arterial revascularization is advocated because of superiority of arterial grafts over venous 
conduits (long term patency and patients survival) and figures of   34%
21
,49.3%
30
 have been quoted. 
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POST-OPERATIVE FACTORS 
Studies show that the mean intensive care unit (ICU) duration which is a proxy for the post-operative 
condition of the patient was between 22-64.8 hours and 31.2-124.8 hours for OPCAB and CABG-CPB 
patients respectively, with most studies showing no significant intergroup differences
8,11,23,25,28,32,36 
 and 
some showing significantly less ICU stay in OPCAB patients 
6,30,38
. The longer ICU duration in 
CABG-CPB patients is attributed to post-operative complications due to systemic inflammatory 
response syndrome (SIRS). Approximately 42% of OPCAB patients will spend < 24 hours in ICU
35
.  
It is known that a longer duration of endotracheal intubation and mechanical ventilation suggests a 
poorer post-operative state and also predisposes the patient to complications such as ventilator 
associated pneumonia. Risk factors for longer ventilation times include; increased age, female gender, 
unstable angina, post-operative IABP use, need for blood transfusion, longer CPB duration, 
haemodynamic instability and renal insufficiency
42
. The mean duration of mechanical ventilation in 
both groups varies between 2.5-17 hours and 9.5-19.5 hours for OPCAB and CABG-CPB patients 
respectively with most studies indicating nil difference between the groups
11, 23 25, 32, 36
 and some 
showing significantly longer duration of mechanical ventilation in CABG-CPB patients
6, 38
. Most 
(80%) OPCAB patients are intubated for < 24 hours
9
. Approximately 35% of both OPCAB and CABG-
CPB patients are ventilated for > 12 hours
35
. Early extubation has been shown to be safe and to 
decrease hospital costs and resource utilization
11
. A subset of patients that have a significantly longer 
ICU stay and mechanical ventilation duration are those who are acutely converted from OPCAB to 
CABG-CPB and this portends a worse prognosis for this group
25
. 
Excessive bleeding plays a key role in the cause of morbidity and mortality after CABG. The aetiology 
of bleeding post CABG-CPB is multi-factorial and includes exposure of the blood to a synthetic, non-
endothelialised surface with subsequent alterations in the coagulation and fibrinolytic systems. A study 
by Casati showed that CABG-CPB patients experienced transient platelet consumption, higher 
plasminogen activation and D-dimer formation than OPCAB patients
43
.The mean volume of post-
operative blood loss among OPCAB patients was 400-950mls and in CABG-CPB patients, 400-818 
mls
22, 25, 34
 with some studies showing less blood loss in OPCAB patients
18
. A significantly higher 
proportion of CABG-CPB patients (31%) had > 500mls of post-operative blood loss versus 16% in 
OPCAB patients
29
. The use of pre-operative anti-platelet agents has been identified as an independent 
risk factor for increased bleeding post CABG
18
. Techniques to reduce intra-operative and post-
operative bleeding in both CABG-CPB and OPCAB patients include the use of aprotinin, epsilon- 
amino caproic acid, tranexamic acid and arginine vasopressin. Other techniques include; use of 
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corticosteroids and intra-operative ultra-filtration both of which serve to reduce the systemic 
inflammatory response associated with CABG-CPB. 
The avoidance of CPB is thought to reduce peri-operative bleeding and consequently decrease the use 
of blood products
22
. Transfusion of allogeneic blood products exposes the patient to extra risks of 
transfusion reactions, immunosuppresion, viral transmission (hepatitis B, C, HIV) and increased 
mortality. Multiple post-operative blood transfusions have also been associated with increased 
morbidity and mortality 
44
. The independent risk factors for both single and multiple unit blood 
transfusion requirements in literature include; advanced age, female gender, increased weight, African 
ancestry, chronic renal failure, left main stenosis, peripheral vascular disease (PVD) and re-operative 
CABG
45
. There have been recommendations that OPCAB should be used in those with these risk 
factors
18
. The proportion of OPCAB and CABG-CPB patients that have red blood cells (RBCs) 
transfused range between 10-55% and 26-86.6% respectively, with most studies showing significantly 
less RBC usage in OPCAB patients
7,25,32,35,46
 and some showing no significant difference between the 2 
groups. The mean number of RBC units transfused is 2-4 units in OPCAB patients and 2-6.1 units in 
CABG-CPB patients.  The median volume of blood received both intra-operatively and post-
operatively was significantly greater in CABG-CPB patients compared to the OPCAB patient group 
with a median of 874mls (range100-10,500mls) and 656mls (range 200-8500mls), respectively (p < 
0.001)
18
. The proportion of patients that require platelet transfusion is between 11-13% and 17-18% of 
OPCAB and CABG-CPB patients respectively
22, 34
, with less platelets transfused in OPCAB patients
35 
and the mean volume transfused in both groups being 1 unit. Clotting factor transfusion is seen in 6.9-
13% and 12.7-19% of OPCAB and CABG-CPB patients respectively
34
 with significantly less 
transfused in OPCAB patients
22,35
; mean volume of fresh frozen plasma (FFP) transfused in OPCAB 
and CABG-CPB patients is 2 and 4 units respectively.  
The incidence of major post-operative complications that comprise; peri-operative myocardial 
infarction (PMI), renal failure, sepsis, deep sternal wound infection (mediastinitis), neurological 
dysfunction (cognitive dysfunction, stroke),re-operation/re-exploration for bleeding, atrial fibrillation, 
low cardiac output syndrome varies among the different studies available. The incidence of PMI varies 
between 0.35-4% and 0.4-3% in OPCAB and CABG-CPB patients respectively 
9, 25,29,34,35,40,41,47
 with 
some showing significantly less rates in OPCAB patients
7
. The maximal post-operative creatinine 
kinase-myocardial band (CK-MB) levels in some studies were significantly lower in the OPCAB 
group
41, 48
. Meta-analyses of the effect of OPCAB surgery have shown a significantly less PMI rate in 
OPCAB patients
49, 50
.  
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Post-operative renal failure increases early mortality (7-38%) 
52, 53, 54
 with a further increase in 
mortality if dialysis (1-5%) is required (60%)
 55
. Cardio-pulmonary bypass was shown to be the main 
cause of glomerular and tubular dysfunction; the markers of glomerular function (creatinine clearance) 
and damage (microalbuminuria) as well as of tubular function (fractional excretion of sodium) and 
damage (urinary N-acetyl-β-glucosaminidase) were found to be significantly higher in CABG-CPB 
patients
56,57
. The causes of deleterious effects of CPB on the kidney are inflammatory response, non-
pulsatile flow, haemodilution, hypoperfusion, low output syndrome, atheroembolism, increased levels 
of circulating catecholamines and free haemoglobin
58, 59
. Post-operative renal failure is seen in 0-5% 
and 0-7.9% of OPCAB and CABG-CPB patients respectively, with dialysis rates of 1.2-5% and 0-5% 
in OPCAB and CABG-CPB patients respectively. The rates are significantly worse in CABG-CPB 
patients 
7,9,29,34,35,38,41,47,51
 in most of the studies and in converted 
25, 40
 and aged (> 80 years) patients
60
.  
Meta-analysis showed significantly lower post-operative RF rates in OPCAB patients
50
. 
The incidence of deep sternal infection (mediastinitis) among the 2 groups was between 0-2% and 1-
8.1% in OPCAB and CABG-CPB patients respectively
9, 26, 32-35, 47
 with one study showing a 
significantly lower rate in OPCAB patients
61
. Meta-analysis showed a significantly lower infection rate 
in OPCAB patients
50
. Deep sternal wound infection is also more common in diabetics where bilateral 
IMA has been used.  
Neurological dysfunction is one of the most studied post-operative complications of CABG. There are 
2 types of neurological dysfunction described; type 1 neurological dysfunction is overt and consists of 
cerebro-vascular accident (CVA) which could be transient or permanent (stroke,coma). type 
2(subtle,cognitive dysfunction-verbal memory,attention,mental flexibility,finger/hand dexterity,visual 
attention and word fluency) is seen in 48-79% of CABG-CPB patients long term and is connected to 
cerebral perfusion
62 
,is usually transient with 2/3 of patients recovering within 6 months, but 1/3  do not 
and some show late decline
63
.  The incidence of stroke in OPCAB and CABG-CPB patients varies 
between 0-3.4% and 1.8-3% respectively, with stroke incidence worse in converted patients
9, 25, 28, 29, 32, 
33, 40
. Many studies have not shown any significant difference in the incidence of early cognitive 
dysfunction between OPCAB and CABG-CPB patients, but meta-analyses have shown significantly 
less stroke rates in OPCAB patients
49, 50, 64
. These indicate that apart from CPB, a major part of the 
immediate post-operative neurological deficit may be related to general and haemodynamic aspects of 
surgery ranging from the microembolic load to cerebral hypoperfusion
36
. The causes of neurological 
dysfunction in CABG include; cerebral embolization of atherosclerotic plaque debris from the 
ascending aorta release during canulation (arterial inflow, cardioplegia) and occlusion (cross-clamping 
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and tangential clamping for proximal graft anastomosis)
 20, 21
. Studies with transcranial Doppler 
ultrasonography have shown a substantial number of emboli production with aortic canulation and 
application, re-adjustment and removal of aortic cross and side clamps. Macroemboli and microemboli 
are most notably detected during application and release of the aortic crossclamp with significant 
neurologic sequelae, making extensive aortic atherosclerosis one of the most significant risk factors for 
post-CABG stroke
20
. The tangential clamp application is an independent predictor of post-operative 
CVA when CPB is not used, while some other studies have refuted this
65, 66
. Others causes of ND on 
CPB include; haemodynamic fluctuations, loss of pulsatile flow, cerebral hypoperfusion and 
coagulation/inflammatory cascade derangement
67
. There are significantly less intra-operative micro-
emboli (solid and gaseous) in OPCAB patients
64
. The risk factors for neurological dysfunction which 
include hypertension, advanced age and carotid artery disease are also risk factors for atherosclerosis
68
. 
The presence of neurologic dysfunction increases chances of mortality significantly. 
Surgical re-exploration of the mediastinum for haemorrhage following OPCAB  
 
and CABG-CPB 
varies between 0-6% and 2-5% respectively
18, 22, 25, 32
 with some studies showing significantly less rates 
in OPCAB patients
7
. Coagulopathy during cardiac surgery with CPB results in impairment of 
haemostasis. The risk factors for re-operation identified include; advanced age, pre-operative 
clopidogrel, left main stenosis, peripheral vascular disease, cardiogenic shock and re-operative CABG 
17, 69. 
Post-operative atrial fibrillation (AF) in 10-36.8% and 9.8-36% of OPCAB  and CABG-CPB  patients 
respectively
9,25,28,32,34,70
,with some showing significantly less rates in OPCAB patients
29
 .The risk 
factors for AF include age which is related to structural changes in the atrium (dilatation, focal fibrosis 
and muscle atrophy). These factors create changes in local atrial refractory period, called 'dispersion of 
refractoriness' resulting in lack of uniformity and in the presence of triggering factors may lead to AF
70
. 
Another theory for development of post-operative AF is atrial denervation response to removal of fat 
tissue from the anterior surface of the ascending aorta for aortic crossclamping and proximal 
anastomotic construction. Atrial ischaemia may also serve as a substrate for development of AF
28
.The 
presence of AF may rarely have a fatal outcome and increases hospital stay, risk of stroke, gastro-
intestinal complications, patient discomfort and costs
28, 70
. The peak incidence is usually between the 
2
nd
 and 4
th
 post-operative day
28, 70
. 
Peri-operative mortality rates for OPCAB and CABG-CPB patients vary between 0-2.8% and 2-17.2% 
respectively
24, 25, 27, 29,34,35,70
 with some studies showing significantly less rates in OPCAB patients
7, 32
. 
The independent risk factors for mortality identified from these studies
7,60,70,71 
include; female gender, 
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age (> 80 years), pre-operative IABP use, CPB use, cardiogenic shock, renal failure requiring dialysis, 
left main stem disease, previous CABG and acute intra-operative conversion from OPCAB to CABG-
CPB. Other studies have refuted the claim that the female gender is an independent predictor of peri-
operative mortality, showing no gender differences in mortality
33, 60
. Acutely converted patients have a 
4 fold increase in peri-operative mortality than in unconverted OPCAB and CABG-CPB patients
35
. The 
causes of death are usually neurologic, pulmonary, renal or multiple organ dysfunction
7, 70
. Meta-
analyses show favourable results of peri-operative mortality with one showing a statistically significant 
reduction in OPCAB versus CABG-CPB patients
49
, which result was not seen in another
49
.  
 The mean post-operative hospital stay (days) for   OPCAB and CABG-CPB patients ranges between 
4-9.3 days and 6.4-16.8 days respectively, with most studies showing significantly longer stays in 
CABG-CPB patients 
6,8,11,25,27-29,32-34
. A meta-analysis showed significantly less hospital stay in 
OPCAB patients
50
.The hospital stay sometimes serves as a surrogate for costs of hospitalization and a 
study showed that OPCAB has a 15-35% reduction in hospital costs
29
.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
34 
 
FOLLOW-UP FACTORS 
 The mean duration of post-operative follow up was between 16.8-38.4 months and 30-40.8 months for 
OPCAB and CABG-CPB patients respectively
 30,32,34,35
. 
Major adverse cardiac event (MACE) comprises the following: angina, congestive heart failure, 
percutaneous coronary intervention, arrhythmia, sudden death. The repeat revascularisation rates have 
been found to be more in OPCAB patients 6-25 months post-operatively, but not significantly so as 
found in one meta-analysis
50
. The MACE rate in CABG-CPB patients was 13.6% in one study
30
, while 
1 year event free rates for OPCAB and CABG-CPB patients are 95.7% and 96.8% respectively. 
Another study did not show any difference in symptoms, quality of life, event-free survival and 
freedom form repeat revascularisation between the 2 groups of patients
29
. The 1 year survival rates 
between the 2 groups are similar with figures of 95.7-98% and 96.1-98% for OPCAB and CABG-CPB 
patients respectively
29, 30, 72
. There is increased late mortality with converted patients, who may have 
poorer anastomoses (an effect of conversion), or some characteristics that predispose them to require 
acute conversion and subsequently to die earlier than unconverted patients for example, an 
underdeveloped or absent collateral circulation
35
. 
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II. AIMS AND OBJECTIVES 
1) To determine the morbidity, mortality and short-term outcomes of off-pump coronary bypass 
surgery performed by a single surgeon in the unit. 
2) To compare (1) with the morbidity, mortality and short-term outcomes of on-pump CABG in 
high risk patients performed by senior surgeons in the unit. 
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III. PATIENTS AND METHODS 
1. DESIGN 
This was a retrospective study of selected ‗off-pump‘ CABG patients and CABG-CPB patients 
operated on by the Department of Cardiothoracic surgery, University of Cape Town/Groote Schuur 
Hospital. It studied patients operated on between January 2001 and December 2007. 
2. LOCATION/ POPULATION 
The Chris Barnard Division of Cardiothoracic Surgery at Groote Schuur Hospital, one of other referral 
centres is a tertiary hospital serving a population of the Western Province of about 4 million with a 
sizeable number from other provinces (Northern and Eastern Cape). 
The division has a clinical ward with a 25 bed capacity exclusively dedicated to the management of 
cardiothoracic surgery patients and also a 6 bed intensive care unit for peri-operative care. 
3. PATIENT SELECTION 
 The inclusion criteria included: 
 - All patients who had isolated  ‗Off-pump‘ coronary artery bypass grafting (OPCAB) during this 
period and operated by a single surgeon (Professor Johan Brink) 
 - All patients who had isolated coronary artery bypass grafting on cardiopulmonary bypass 
(CABG/CPB) during this period and operated by 2 senior surgeons in the unit (Professor Peter 
Zilla, Professor Johan Brink) 
 - Above 2 criteria were chosen to eliminate the learning curve associated with surgical procedures 
as the 2 senior surgeons have advanced beyond the learning curve stages. 
 The exclusion criteria included: 
 - All patients who had CABG/CPB or OPCAB during the period under study and NOT operated 
by any of these 2 surgeons. 
 - Combined procedures involving CABG. 
 
4. CONSENT AND ETHICS  
Institutional consent was obtained from the University of Cape Town‘s Faculty of Health Sciences 
Ethical and Research Committee. No consent was obtained from the patients as this was a retrospective 
study and no patient confidentiality was breached. 
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5. DATA COLLECTION 
The data collected for each patient was enumerated in the data collection sheet (attached). 
The data was accessed from the following sources; 
1) The ‗Filemaker‘ cardiac surgery database belonging to the Chris Barnard Division of 
Cardiothoracic Surgery. 
2) Patients‘ Groote Schuur Hospital folders and hospital records. 
3) Patients‘ records in the Cardiac Clinic, Groote Schuur Hospital. 
 
6. DATA ANALYSIS 
 The data generated from this study was analyzed using STATA 10 and Microsoft Excel software.  
Categorical variables were analysed with the Pearson's chi squared test and Fisher‘s exact test when 
outcome variables were less than 5. The continuous variables between the 2 groups were analysed with 
the Student t test. Continuous variables were depicted as ranges, mean and standard deviation. A value 
of p < 0.05 was set as statistical significance. 
 
7. LIMITATIONS OF THE STUDY 
These may include: 
1) Some loss of pertinent information associated with retrospective studies. However, all peri-
operative data elements were prospectively entered into a cardiac surgery research database 
according to pre-specified definitions. 
2) There was no measurement of graft patency. 
3) The patients enrolled in the study were not randomized to either group and only those suitable, 
according to the surgeon, were selected as candidates for OPCAB surgery. There was no way of 
ascertaining reasons why one technique was preferred over another for particular patients. 
4) Our study was performed in a single institution with a single surgical group, which may bias the 
operative data. 
5) There was no risk stratification for the patients possible. The objective EUROSCORE 
assessment and relevant data captured was only included in the departmental database from 
2007 onwards. Generally, however, lower risk coronary patients had their surgery done by less 
senior surgeons and the high risk patients almost exclusively by the 2 senior surgeons. 
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IV. RESULTS 
TOTAL POPULATION 
Three hundred and forty two (342) patients that fulfilled the criteria had records available for 
review from the data sources and were operated between January 2001 and December, 2007. There 
were 199 OPCAB patients and 143 CABG-CPB patients. 
 
PRE-OPERATIVE FACTORS 
There was no significant difference in age at operation between the 2 groups, with the mean ± 
standard deviation (SD) for OPCAB and CABG-CPB patients being 59.2 ± 10.5 years and 60.1 ± 
9.6 years respectively. The age range was 23.4-84.3 years and 33.9-84.8 years for OPCAB and 
CABG-CPB patients respectively. Most of the patients were between 50-70 years; 63.2% and 
68.3% of OPCAB and CABG-CPB patients respectively. Tables 1 and 2 show the pre-operative 
characteristics between the 2 groups. 
The distribution of gender did not reveal any significant differences between the 2 groups.  The 
female gender comprised 25.1% (male, 74.9%) and 26.6% (male, 73.6%) of OPCAB and CABG-
CPB patients respectively.  
There was no significant difference in the incidence of obesity in both groups. 
The proportion of the patients that had previous MI was 55.3% and 58.3% of OPCAB and CABG-
CPB patients respectively, without any significant difference between them. 
The incidence of hypertension in both groups was not significantly different with 65.1% and 69% 
of OPCAB and CABG-CPB being hypertensive respectively. 
Diabetes mellitus (DM) was seen in 30.4% and 35.9% of OPCAB and CABG-CPB patients 
respectively, without any significant intergroup differences. 
The incidence of COPD was 13.8% and 7.1% in OPCAB and CABG-CPB patients respectively, a 
difference which did not quite reach statistical significance (p= 0.053).  
The incidence of pre-operative renal failure was 3% and 2.1% in OPCAB and CABG-CPB patients 
respectively without a significant intergroup difference. The mean pre-operative creatinine value 
was 96.5 and 90 for OPCAB and CABG-CPB patients respectively, with no statistical significance 
between the 2 groups of patients. 
Previous CVA was present in 3.1% and 2.8 % of OPCAB and CABG-CPB patients, and without 
significant difference between them. 
The proportion of patients who were smokers was 75.5% and 71.8% in OPCAB and CABG-CPB 
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patients respectively and this was not significantly different.  
Hypercholesterolaemia was present in 58.3% and 58.8% of OPCAB and CABG-CPB patients and 
without any significant difference in distribution between the 2 groups. 
The incidence of PVD was 9.2% and 9.9% in OPCAB and CABG-CPB patients respectively with 
no significant difference between the 2 groups. 
Positive family history of CAD was significantly more present in OPCAB patients with a figure of 
69% versus 55.1% for CABG-CPB patients (p=0.009). 
Most of the patients in both groups were on aspirin pre-operatively, 85.1% and 85.4% of OPCAB 
and CABG-CPB patients respectively and there was nil difference between the 2 groups. The mean 
duration of aspirin stoppage pre-operatively was 3.51 days and 3 days for OPCAB and CABG-CPB 
patients respectively, also without any intergroup difference. 
Pre-operative AF was present in 9.2% and 8% of OPCAB and CABG-CPB patients respectively 
and this too, did not show any significant intergroup difference. 
 About 50.8% of OPCAB patients were pre-operatively in NYHA classes III/IV versus 50.7% in 
CABG-CPB patients and there was no significant difference between the 2 groups, while there 
tended to be more CABG-CPB patients in CCS classes III/IV (81.4%) versus 74.6% in OPCAB 
patients, but this superiority did not meet statistical significance p=0.154). 
A larger proportion of CABG-CPB patients had an IABP pre-operatively (12.8%) compared to 
9.5% of OPCAB patients, but this did not meet statistical significance. 
The mean left ventricular ejection fraction (LVEF) was 56.9 and 56.7 for OPCAB and CABG-CPB 
patients respectively with most patients in both groups having a good LVEF (> 50); OPCAB 
(74.3%) and CABG-CPB (72.1%). However, there was no significant difference in these 2 values 
for these 2 groups.  
Some of the patients in both groups had 1undergone prior percutaneous coronary intervention (PCI) 
with figures of 13.6% and 7.7% in OPCAB and CABG-CPB patients respectively and the larger 
OPCAB proportion tended to, but did not translate into statistical significance (p=0.088). 
A small percentage of patients in both groups had a previous cardiac operation, 5.6% and 2.9% in 
OPCAB and CABG-CPB patients respectively, without any intergroup difference. 
There was a larger proportion of CABG-CPB patients who had urgent/emergency surgery (44.9%) 
versus 34.2% of OPCAB patients and this tended to, but was not statistically significant (p=0.169). 
The indication for surgery was unstable angina/acute MI in 70% and 70.5% of OPCAB and CABG-
CPB patients respectively and there was no intergroup difference. 
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INTRA-OPERATIVE FACTORS 
The proportion of patients who were acutely converted from OPCAB to CABG-CPB was 2.5% 
(n=5). The reasons for conversion were haemodynamic instability in all the cases. Conversion was 
not a risk factor for death in this study. Tables 3 and 4 show the intra-operative characteristics of 
both groups. 
The mean CPB duration for CABG-CPB was 123 minutes, while the mean aortic crossclamp 
(ischaemic) time was 76.7 minutes. 
The use of the cell saver was significantly more in OPCAB patients (26%) versus 6.4% in CABG-
CPB and this was not unexpected. 
There was no significant difference in the mean number of distal anastomoses done and this was 
3.31 grafts and 3.45 grafts in OPCAB and CABG-CPB patients respectively. The proportion of 
patients in both groups who had a LIMA-LAD graft was 93.4% and 90 % in OPCAB and CABG-
CPB patients respectively and without any intergroup difference. Table 5 shows the different 
distribution of target vessels and conduits between the 2 groups. Significantly more right IMA and 
radial arteries were used in OPCAB patients, while significantly more saphenous vein grafts (SVG) 
were used in CABG-CPB. Significantly more OPCAB patients (26%) had total arterial 
revascularization (TAR), compared to 4.3% in CABG-CPB patients.  
 
POST-OPERATIVE FACTORS 
The mean duration of ICU stay was less in OPCAB patients (80.7 hours) versus 104 hours in 
CABG-CPB patients, but there was no statistical significance. Significantly more OPCAB patients 
had < 24 hours ICU stay (8.4%) than CABG-CPB patients (3.4%). Tables 6 and 7 show the 
different post-operative characteristic between the 2 groups. 
The mean duration of mechanical ventilation was 22.3 hours and 38.3 hours in OPCAB and 
CABG-CPB patients respectively and this tended towards but was not statistically significant 
(p=0.09). A larger proportion of CABG-CPB patients (24.6%) versus OPCAB patients (14%) were 
ventilated for > 24 hours. 
The mean ICU blood loss was significantly less with OPCAB patients (808 mls) than CABG-CPB 
patients (988 mls). 
 A larger proportion of CABG-CPB patients needed ICU red blood cell transfusion (48.3%) versus 
20.1% in OPCAB patients and there were significantly more mean number of RBC units transfused 
in CABG-CPB patients (2.66) versus 1.72 units in OPCAB patients. 
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Though post-operative MI was seen in a larger proportion of OPCAB patients (2.5%) than CABG-
CPB patients (0.7%), the difference was not statistically significant.  
There was no significant difference in the rate of post-operative renal failure between OPCAB (4%) 
and CABG-CPB (7%) patients. 
Post-operative ICU septicaemia was significantly more common in CABG-CPB (5.6%) than in 
OPCAB (1.5%) patients.   
The incidence of post-operative pneumonia was 8.5% and 7% in OPCAB and CABG-CPB patients 
respectively, without a significant intergroup difference. 
There was a significantly higher incidence of deep sternal wound infection (mediastinitis) in 
CABG-CPB (4.2%) versus 0.5% in OPCAB patients. 
Post-operative CVA was seen in 1% and 5.6% of OPCAB and CABG-CPB patients respectively 
and the difference was statistically significant. 
Though there was a higher incidence of post-operative AF in CABG-CPB patients (4.2%)   
compared to 2% of OPCAB patients, this was not statistically significant. 
There was no difference in the incidence of re-exploration for haemorrhage between OPCAB (1%) 
and CABG-CPB (2.8%) patients. 
Death rates were 3% and 9% in OPCAB and CABG-CPB patients respectively and the higher 
CABG-CPB rate was statistically significant.  However, a limitation of this study was the 
inabilities to risk stratify the patients retrospectively. 
The mean post-operative stay in the ward was significantly less in OPCAB patients at 5.5 days 
compared to 7.4 days by CABG-CPB patients. 
 
FOLLOW UP FACTORS 
The follow-up data was available for 49.2% (n= 104) and 68.5% (n=92) of OPCAB and CABG-
CPB patients respectively, and the mean follow-up duration was 17.8 months and 15.2 months 
respectively without any statistically significant difference between the groups. 
Tables 8 and 9 show the follow-up variables between the 2 groups. 
Of these patients the angina recurrence rate during the follow up period was not significantly 
different between the groups, being 18.3% (18 of 98) and 20.4% (20/98) in OPCAB and CABG-
CPB patients respectively. The recurrence of angina on average was significantly sooner in 
OPCAB patients at 8.3 months compared to 23.4 months in CABG-CPB patients.  
The MACE rate was also similar between the 2 groups being 20.4% and 23.4% in OPCAB and 
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CABG-CPB patients respectively. 
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V. DISCUSSION 
Off-pump coronary artery bypass grafting (OPCAB) has been in existence since the 1960s and was 
initially a technique for CABG, but which went out of favour with the advent of CPB and 
cardioplegic arrest. 
As time passed and with increased CPB use, the deleterious effects of CPB became more obvious 
and efforts were then directed at prevention or reduction of these negative effects. This led to the 
resurgence of OPCAB surgery in the early 1990s. The thinking was, elimination of CPB would 
lead to a more physiological milieu that would optimize organ function and reduce organ specific 
complications especially in high risk patients.  
South Africa is a unique country in the sense that it has both traditionally 'western' diseases (CAD) 
and cardiac diseases associated with low socio-economic situations (rheumatic heart disease) and is 
economically classified as a developing country. 
This classification positions it to reap the perceived advantages of OPCAB over CABG-CPB 
which early studies showed. 
This study was done to explore the presence of any advantage off OPCAB over CABG-CPB peri-
operatively and also in the short/mid term. 
  
PRE-OPERATIVE CHARACTERISTICS 
The demographics among the 2 groups did not show any significant difference except for family 
history of CAD which was significantly more common in OPCAB patients.  
When this study‘s figures were compared to figures found in the literature, there were no 
significant differences found. Table 10 shows the figures found in the literature. The variables 
compared include; age, female gender, previous MI, hypertension, DM, renal failure, previous 
CVA, smoking and hypercholesterolaemia. Other variables compared include; PVD, COPD, family 
history of CAD, use of pre-operative aspirin, presence of pre-operative AF, NYHA and CCS 
classes, use of pre-operative IABP, previous cardiac operation and previous PCI. 
The mean LVEF of 56.9% and 56.7%  for OPCAB and CABG-CPB patients respectively was 
similar to 50-65% and 45-63% seen in other studies
49,73,88,99-101
, with one being significantly more 
in OPCAB patients
99
. The proportion of patients in the 2 groups with low LVEF(< 30%) was 5.9% 
and 5.3% for OPCAB and CABG-CPB patients respectively and was also similar to figures of 1.9-
8.6% and 2.3-8.2% found in other studies
 72,75,76,98,99,
.  
Though this was a retrospective study, indications for pre-op IABP use gleaned from other studies 
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included; cardiac index < 1.8, haemodynamic instability, severe left ventricular dysfunction and 
high grade left main stenosis
83
. The use of IABP has also being found to be an independent risk 
factor for 30 day mortality
90, 94
. The figures of 9.5% and 12.8% for OPCAB and CABG-CPB 
patients respectively, are similar to those found in the literature of 1-10% and 4-11.6% for OPCAB 
and CABG-CPB patients respectively
46, 74, 79-81, 85, 89, 94
. Though there was a higher rate of usage in 
CABG-CPB patients and no intergroup difference in this study, many studies showed significantly 
less IABP rates pre-operatively in OPCAB patients
79-81
. This may suggest a higher percentage of 
high risk patients in CABG-CPB group. 
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INTRA-OPERATIVE CHARACTERISTICS 
The priority of the patients' operation as urgent/emergent was 34.1%  and 43.9% in OPCAB and 
CABG-CPB patients respectively and there was no difference between the groups, though a larger 
proportion had urgent/emergent surgery in CABG-CPB. These figures compare with 21-70.9% and 25-
74.3% for OPCAB and CABG-CPB patients respectively from other studies
 37,73,79,81,89,90,94,102
. Most of 
the studies had a significantly higher proportion of CABG-CPB patients having urgent/emergent 
surgery 
37, 79-81,102
. This larger proportion may be a surrogate for the worse clinical condition of the 
CABG-CPB patients which may also explain the higher mortality rate in CABG-CPB patients. There 
was a significant difference in mortality rates between elective and urgent/emergent cases being worse 
in the latter. 
The initial application of OPCAB in the early 1990s was directed mainly at highly selected and 
relatively low risk patients. Early evidence suggested potential advantages of OPCAB and many 
surgical units have experienced an increased percentage of OPCAB usage with time and later high risk 
patients with risk factors that make them susceptible to the negative effects of CPB have been added to 
the patient pool
89
.The OPCAB advantages elucidated include; eliminating intra-operative global 
ischaemia, lower mortality,lower morbidity, lower costs and less use of blood products
82
.Other 
advantages include lower rates pulmonary infection, necessity for vaso-active drugs, bleeding, blood 
transfusion and ICU stay
82
. The disadvantages listed include; more time in operating room, lower 
number of grafts
81 
and regional ischaemia. Conversion to non-selective application of OPCAB did not 
increase morbidity nor lead to a change of practice
103
. Presently OPCAB can be performed for lesions 
in virtually any coronary artery with a high degree of patient safety and surgeon comfort
84
. The 
proportion of CABG cases as OPCAB across many units has steadily increased since the inception. 
One study quoted increasing percentages from 6% in 1997 to 99% in 2002
99
. The range in literature is 
between 20 and 99%
 46,72,79,87,89,90,99,104
. 
The mean CPB  and aortic cross-clamp times in this study of 123minutes and 76.7 minutes respectively 
were higher than in other studies which reported ranges of 57-169 minutes and 29-64 minutes 
respectively
 41,46,75,77,79,82,89,96,105
. These longer times can be attributed to the high risk profile of our 
patients. The deleterious effects of CPB are well known and include evoking an inflammatory response 
with evidence of complement activation and free radical generation
76
. These effects then lead to renal, 
pulmonary, neurologic complications, bleeding and multiple organ dysfunction
79
. All these combine to 
an increase in hospital stay
84, 87
. 
The mean number of distal anastomoses in this study was 3.31 and 3.45 for OPCAB and CABG-CPB 
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patients respectively without any significant intergroup difference. These figures are similar to 1.8-3.5 
and 1.7-4 grafts reported in other studies
 37,41,46,72,73,82-89,97
 However, most of these studies show a 
significantly higher number of grafts in CABG-CPB patients 
37
,
46,73,83,84,86-88
. A recent prospective 
randomized study; ROOBY showed fewer grafts in the OPCAB patients 
106
. These results were 
identified as one of the earliest disadvantages of OPCAB, but in some centres, with increasing 
knowledge and experience with the OPCAB technique, minimal differences in mean number of distal 
anastomoses were noticed between OPCAB and CABG-CPB patients. The similarity in the number of 
grafts in this study rules out the possibility of incomplete revascularisation in OPCAB patients 
previously suggested and allows for better comparison between the 2 groups
89
. Furthermore the 
absence of a significant difference in distribution of the distal anastomoses to the vascular territories 
decreases the possible bias that could be involved in the selection of the procedure
89
.   The LAD was 
the target vessel in 98% and 98.5% in OPCAB and CABG-CPB patients respectively, figures that are 
similar to 100% and 95-97.8% seen in other studies
73,86,93
.  The diagonal arteries were the target vessels 
in 54.1% and 54.3% of OPCAB and CABG-CPB patients respectively and without intergroup 
differences and also similar to 48.4-70% and 54.3-71% respectively seen in other studies
73, 86, 93
. The 
obtuse marginal arteries were the target vessels in 77.5% and 84.8% in OPCAB and CABG-CPB 
patients; figures higher than 54.8-69% for OPCAB patients, but similar to 89-100% reported for 
CABG-CPB patients
73, 86
. One study showed a significantly more OM graft rate in CABG-CPB 
patients and this may be related to the difficulty of grafting the lateral surfaces of the heart in OPCAB 
(increased likelihood of haemodynamic instability)
86
. The RCA (excluding PDA) was a target vessel 
significantly more times in CABG-CPB (13%) than OPCAB (4.6%) patients. These figures are much 
lower than 22.6-32% seen in OPCAB patients, but similar to 10.9-43% in CABG-CPB patients
73, 86, 93
. 
This may also be explained by the technical and physiological difficulty of grafting the RCA in 
OPCAB. The PDA was the target vessel in 62.7% and 54.3% of OPCAB and CABG-CPB patients 
respectively and these are similar to 27-51.6% and 29-80.4% for OPCAB and CABG-CPB patients 
respectively seen in other studies
73, 86
, with one showing significantly higher rates in CABG-CPB
107
. 
The LIMA is recognized as the ideal graft for the LAD
41
 and was used as conduit in 93.4% and 90.4% 
of OPCAB and CABG-CPB patients respectively in this study. These figures are similar to 34-100% 
and 35-95.6% in OPCAB and CABG-CPB patients respectively seen in other studies. The use of the 
RIMA as a conduit was significantly more at 6.1% in OPCAB patients than 0.7% in CABG-CPB 
patients. This may reflect surgeon's preference, higher percentage of urgent/emergent cases and also 
correlates with a higher rate of total arterial revascularization (TAR) seen in OPCAB patients (26% 
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versus 4.3%). These RIMA figures are similar to 1.7-17.2% and 1-16% seen in OPCAB and CABG-
CPB patients respectively
41, 73,79,86,93
.  The SVG is the most widely used graft because of its 
accessibility and ease of use
73 
and was used as a conduit in this study in significantly more CABG-CPB 
patients (95%) than OPCAB patients (73.5%). These figures are similar to 60.7-90.3% and 90.8-97.8% 
for OPCAB and CABG-CPB patients respectively found in other studies
73, 86, 93 
with one study showing 
a significantly higher SVG use in CABG-CPB patients
101
. This figure reflects ease of harvesting the 
conduit and a higher urgent/emergent case rate seen in CABG-CPB patients. The RA was the conduit 
in significantly more OPCAB patients (25%) than CABG-CPB (11.6%); figures that are much higher 
than 2.9-8.2% in OPCAB patients, but similar to 3.1-13% for CABG-CPB patients seen in other 
studies
73, 86, 93
. This may also reflect a higher TAR pursued in OPCAB patients in this study. 
Conversion intra-operatively from OPCAB to CABG-CPB was necessary in 2.5% of OPCAB patients 
with the reason being haemodynamic instability in all cases. This figure is similar to 0-13.3% seen in 
other studies
 41, 74,79,83,84,102
. One study attributed its high rate of conversion (13.3%) to variable surgeon 
experience and high percentage of 3 vessel CAD in their patient cohort.  Conversion has been 
associated with higher morbidity, mortality and increased hospital costs
74
; findings that are absent in 
this study. The most common reasons for conversion include; ischaemia, inability to visualize a target 
vessel and haemodynamic instability. 
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POST-OPERATIVE CHARACTERISTICS 
The mean peri-operative blood loss in this study was 808mls and 988 mls in OPCAB and CABG-CPB 
patients respectively and this was significantly more in the CABG-CPB group. These figures are 
similar to 503-789mls and 560-1389 mls reported for OPCAB and CABG-CPB patients respectively in 
other studies
41, 48, 82, 88
, most of which show significantly more blood loss in CABG-CPB patients. 
Though many studies report less peri-operative blood loss with the OPCAB technique, an area of 
concern is the uncertainty of an existing pro-coagulant or hypercoagulant state in OPCAB operations. 
This may endanger graft patency peri-operatively. The factors that activate coagulation in CABG-CPB 
are well defined and include contact of blood with the foreign surfaces of the extra-corporeal circuit, 
blood air contact in the open venous reservoir as well as use of the cardiotomy suction
96
. 
Red blood cell transfusion was needed in 20% and 48.3% of OPCAB and CABG-CPB patients 
respectively; significantly more in CABG-CPB patients. These figures are similar to 10-52% and 26-
56.2% for OPCAB and CABG-CPB groups respectively, with one randomised controlled trial showing 
a significantly more need for RBC transfusion in CABG-CPB patients 
41, 46, 82,106
.   Different blood 
transfusion rates may be because of different transfusion guidelines and indications in the units and the 
use of cell saving devices
41
. The mean RBC units transfused was significantly more for CABG-CPB 
patients at 1.72 and 2.66 for OPCAB and CABG-CPB patients respectively; figures similar to 1.2-4 
units and 2.9-6.1 units for OPCAB and CABG-CPB patients respectively
41,82,88
. 
The mean duration of ICU stay was higher but not significantly so in CABG-CPB patients at 104.1 
hours versus 80.7 hours in OPCAB patients. These correlate with figures of 29.3-93.6 hours and 22-
124.8 hours in OPCAB and CABG-CPB patients respectively, with some studies not showing any 
intergroup difference
41,74,77,82,97,100,105,106,108
 and others showing significantly more time spent in ICU by 
CABG-CPB patients
77,87,89
. The identified risk factors for prolonged stay in ICU include; lung disease, 
no sinus rhythm, reoperation and no elective operation
108
 .It must be conceded though that local ICU 
bed availability may influence ICU stay duration.  
 The mean duration of mechanical ventilation among OPCAB patients (22.3 hours) was less than that 
for CABG-CPB patients (38.3 hours), but not significantly so and was higher than figures of 8.4-17.1 
hours and 4-22.2 hours in other studies
41, 74, 82, 97,100,106
. Many studies report significantly longer 
ventilator hours in CABG-CPB patients
77, 86,109
. This discrepancy cannot be adequately explained by 
the pre-operative or intra-operative characteristics of patients in this study. The duration of mechanical 
ventilation is an important surrogate for costs and early endo-tracheal extubation has been shown to 
decrease costs
87
. 
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The incidence of post-operative renal failure among OPCAB and CABG-CPB patients was 4% and 7% 
respectively, without any intergroup difference and similar to 0-3.8% and 0-6.2% respectively. Most of 
the studies show no difference between the groups
41, 47,73,77,79,81,83,89,106,110
, while some show a higher 
rate in CABG-CPB patients. Logistic regression did not show post-operative renal failure to be a risk 
factor for death in this study unlike in another study
51
.  
 The incidence rate of post-operative stroke (Type 1 neurologic deficit) was significantly more in 
CABG-CPB at 5.6% versus 1% in OPCAB patients and these figures were within ranges of 0-2% and 
0-7% for OPCAB and CABG-CPB patients respectively. There are conflicting reports with some 
showing no intergroup difference
37,47,73,74,81-84,89,97,102,105,106
 and others showing a significantly higher 
rate in CABG-CPB patients
46,79,110
. A meta-analysis showed a trend towards the reduction of strokes in 
OPCAB patients, while a recent randomised controlled study showed no difference between the 2 
groups in incidence of post-operative stroke
106
. The risk factors identified for strokes from previous 
studies include; advanced age, history of previous strokes, redo cardiac surgery and history of PVD
46, 
91
. The mechanisms for stroke in OPCAB patients include; haemodynamic changes, use of the partial 
occlusion aortic clamp and a decrease in cerebral perfusion by myocardial dislocation, while for 
CABG-CPB patients  include; cerebral emboli (atheromatous), usually more in CABG-CPB, and 
cerebral hypoperfusion
41,88
.  
 There was a higher rate of postoperative MI in OPCAB patients (2.5%) compared to 0.7% in CABG-
CPB, similar to 0-3.7% and 0-7.5% in OPCAB and CABG-CPB patients respectively in other studies
, 
41, 47, 73,74,81,82,84,89,94,110
. Most studies showed a higher rate, though insignificant in CABG-CPB patients, 
with no intergroup differences unlike in this study. Studies have shown that in routine clinical practice, 
the OPCAB technique is associated with significantly reduced post-operative cardiac enzyme (troponin 
I, CK-MB) release compared to CABG-CPB suggesting significantly lower levels of perioperative 
myocardial injury
72, 83, 97,111
. Perioperative CK-MB release has been shown to be a reliable marker for 
myocardial ischaemia and injury in both OPCAB and CABG-CPB patients
72
. A meta-analysis showed 
a trend towards reduction in incidence of post-operative MI in OPCAB patients. Some have attributed 
the different concepts of regional ischaemia in OPCAB and global ischaemia in CABG-CPB caused by 
aortic crossclamping as the reason for the myocardial protective effect of the OPCAB technique
89
.  
 Deep sternal wound infection (mediastinitis) was found post-operatively in significantly more CABG-
CPB patients (4.2%) compared to 1% in OPCAB patients. Most of the studies showed no significant 
intergroup difference in the incidence rate of mediastinitis, but these figures were within the range of 0-
3.5% and 0.3-3.7% for OPCAB and CABG-CPB patients respectively
 37, 47, 73, 77, 79, 82-84,105,106,110
. 
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Cardiopulmonary bypass causes leucocyte dysfunction and coupled with increased tissue oedema and 
cytokine activation may explain the trend towards a decrease in postoperative mediastinitis in OPCAB 
patient
84
. 
 There was no intergroup difference in the rate of re-exploration for haemorrhage between OPCAB 
patients (1%) and CABG-CPB patients (2.8%); figures similar to 0-7.1% and 1.4-6.7% of OPCAB and 
CABG-CPB patients respectively in other studies. Some of the studies  show significantly higher rates 
in CABG-CPB patients
46,79,87,110
, while others do not
 37,73,77,81-84,87,89,97,102
. 
The mean duration of postoperative hospital stay was significantly less in OPCAB patients (5.5 days) 
when compared to CABG-CPB patients (7.4 days) and these figures were similar to 3-10.9 days and 4-
12.3 days for OPCAB and CABG-CPB patients respectively. Many studies showed a significantly 
longer stay by CABG-CPB patients
37,75,79,81,83,87,110
, while others showed no difference
 46,82,84,89,97,100,106
. 
The factors associated with increased postoperative hospital stay include; CPB use, RBC transfusion, 
increasing age, female gender and increased mechanical ventilation duration
87.
Cardiopulmonary bypass 
use was found to be an independent predictor for increased postoperative stay
84
.
  
 The incidence of peri-operative mortality was significantly different between the 2 groups at 3% and 
9% for OPCAB and CABG-CPB patients respectively. These figures are similar to 0-3.5% and 0-12% 
for OPCAB and CABG-CPB patients respectively, though most studies showed no significant 
difference between them
 37,41,46,47,73,74,76,80,82-84,88,97,102,105,106,110
 and some showed more deaths with the 
CABG-CPB technique
 79,81,87,89
. Risk factors for mortality include; intra-operative conversion from 
OPCAB to CABG-CPB
74
, age, female gender, carotid artery disease, chronic renal failure, low LVEF, 
pre-operative IABP and recent MI
80,84
. In our series the higher mortality can be attributed to the fact 
that during the time period of the study, all the higher risk patients were assigned to the 2 senior 
surgeons in the study. It was not possible retrospectively to do an objective risk assessment (such as 
EUROSCORE, PARSONNET or STS risk evaluation), due to data being incomplete in majority of our 
patients. 
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FOLLOW UP CHARACTERISTICS 
In this study the rate of angina recurrence was similar between the 2 groups, but with an earlier 
recurrence in OPCAB patients. This is difficult to explain this because there was no significant 
difference in the number of distal anastomoses between the 2 groups; lower number of grafts in 
OPCAB patients was the reason proposed for earlier angina recurrence and higher rates of angina 
recurrence in OPCAB patients in the past. There was significantly less SVG use and significantly 
higher total arterial revascularisation rate in OPCAB patients in this study, factors that should have 
ensured lesser angina recurrence rates. The long-term patency of grafts is one of the major factors that 
determine MACE components like angina. The patency rate of arterial grafts after OPCAB is 
comparable to arterial grafts done by CABG-CPB
73
.It may be that the use of SVG in OPCAB played a 
more important role in angina recurrence. Saphenous vein grafts after OPCAB in the early post-
operative period have been shown to have slightly lower patency rates than arterial grafts and also a 
significantly lower patency rate 1 year post-operatively, than SVG done with CABG-CPB
48, 73
.   The 
patency of SVG after CABG is affected by 3 processes that cause SVG failure; thrombosis, fibro-
intimal hyperplasia and vein graft arteriosclerosis. Among the 3 processes, thrombosis accounts for 
most graft failures within the first month, but may continue for as long as 1 year post-CABG. Fibro-
intimal hyperplasia occurs predominantly after 1 month to 5 years and SVG arteriosclerosis may begin 
as early as the first year, but is fully developed only after 5 years
73
. Some authors have proposed sub-
optimal anastomoses as the reason for poorer graft patency rates in OPCAB patients (a surrogate for 
angina recurrence)
 41
. A recent randomised trial also showed lower graft patency rates in OPCAB 
patients at 1 year
106
. 
There was no difference between the MACE rates during the limited follow up period; a finding 
confirmed by some studies
72
 and refuted by others reporting MACE rates in CABG-CPB patients 
81,110 
. 
The reported disadvantages of OPCAB; frequent incomplete revascularisation resulting in increase in 
cardiac events were not evident during the short follow up period
77
.  
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VI. CONCLUSION 
The conclusion of this study is as follows; 
1) There were similar pre-operative characteristics between the OPCAB and CABG-CPB patients. 
2) There was less ICU blood loss and less usage of blood products in OPCAB patients. 
3) There was shorter hospital stay in OPCAB patients. 
4) There were lower rates of sepsis, deep sternal wound infection and post-operative stroke in 
OPCAB patients. 
5) Peri-operative mortality was lower in OPCAB patients. 
6) There was an earlier recurrence of angina in OPCAB patients, but the same overall rate. 
7) There was no difference in major adverse cardiac events during the limited follow-up period. 
8) An obvious cost savings in OPCAB patients due to 
a) Lower cost of consumables. 
b) Less blood usage. 
c) Shorter hospital stay 
d) Lower rates of sepsis, infection and strokes. 
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TABLES AND FIGURES 
Table 1: Preoperative Characteristics (Categorical Variables) 
 OPCAB (N=199) CABG-CPB (N=143)  
 Available 
data 
Factor 
Present 
% Available 
data 
Factor 
Present 
% P value 
Gender(F) 50  25.1 38  26.6 
0.76 
Gender(M) 149  74.9 105  73.4 
Obesity 141 42 30 118 34 29 0.76 
MI 197 109 55.3 141 83 58.9 0.52 
Hypertension 198 129 65.1 142 98 69 0.46 
DM 197 60 30.4 142 51 35.9 0.29 
COPD 196 27 13.8 141 10 7.1 0.05 
Renal Failure 195 6 3 141 3 2.1 0.6 
Previous 
CVA 
192 6 3.1 141 4 2.8 0.88 
Smoking 196 148 75.5 142 102 71.8 0.45 
Hyper CHL 197 115 58.4 141 83 58.9 0.93 
PVD 195 18 9.23 141 14 9.92 0.83 
CAD Family 
History 
194 134 69 143 79 55.2 0.01 
Pre-op 
Aspirin 
195 166 85.1 137 117 85.4 0.95 
NYHA I 
197 
27 13.7 
138 
19 13.8 
0.74 
II 70 35.5 49 35.5 
III 67 34 41 29.7 
IV 33 16.8 29 21 
CCS    I 
197 
9 4.6 
139 
1 0.7 
0.15 
II 41 20.8 25 18 
III 80 40.6 55 40 
IV 67 34 58 41.7 
AF 195 18 9.2 138 11 8 0.69 
IABP 189 18 9.5 133 17 12.8 0.36 
Previous 
cardiac 
Operation 
197 11 5.6 137 4 2.9 0.25 
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Previous PCI 199 27 13.6 143 11 7.7 0.09 
 
Legend 
- MI: Myocardial Infarction 
- COPD: Chronic Obstructive Pulmonary Disease 
- CVA: Cerebro-Vascular Accident 
- HyperCHL: Hypercholesterolaemia 
- PVD: Peripheral Vascular Disease 
- CAD: Coronary Artery Disease 
- NYHA: New York Heart Association 
- CCS. Canadian Cardiovascular Society 
- AF: Atrial Fibrillation 
- IABP: Intra-aortic balloon pump 
- PCI: Percutaneous Coronary Intervention  
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                                                                  Table 2: Preoperative Characteristics (Continuous Variables) 
 OPCAB (N=199) CABG-CPB (N=143)  
 Available 
data 
Min Max Mean ST Dev Available 
data 
Min Max Mean ST Dev P value 
Age(years) 199 
 
23.4 84.3 59.2 10.54 142 33.9 84.8 60.1 9.66 0.42 
BMI 141 17.1 47.4 28.3 4.65 118 19.3 40.6 28.1 4 0.76 
ASI(Days) 146 0 17 3.51 3.16 96 0 14 3.06 2.73 0.26 
LVEF 187 13 88 56.9 14.74 133 20 92 56.7 13.4 0.91 
Pre-op 
Creatinine 
164 43 525 96.5 50.7 121 49 164 90.7 24.8 0.25 
 
Legend 
- BMI: Body Mass Index 
- ASI: Aspirin Stoppage Interval 
- LVEF: left Ventricular Ejection Fraction 
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Table 3: Intra-Operative Characteristics (Categorical Variables) 
 OPCAB(N=199) CABG-CPB(N=143)  
 Available 
Data 
Factor 
Present 
% Available 
Data 
Factor 
Present 
% P Value 
Priority of 
Operation 
 Elective 
199 
131 65.8 
139 
78 56.1 
0.17 
 Urgent 53 26.6 50 36 
 Emergency 15 7.5 11 7.9 
Cell Saver 
Use 
196 51 26 140 9 6.4 0 
IABP use 198 17 8.6 139 24 17.3 0.03 
        
Legend 
IABP: Intra-aortic balloon pump 
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                                                    Table 4: Intra-Operative Characteristics (Continuous Variables) 
 OPCAB(N=199) CABG-CPB(N=143)  
 Available 
data 
Min Max Mean ST Dev Available 
data 
Min Max Mean ST Dev P Value 
Distal Anastomoses 196 1 5 3.31 0.9 139 1 5 3.45 0.83 0.15 
CPB Duration 
(Minutes) 
     118 12 432 123.4 47  
Aortic Cross-clamp 
Duration(Minutes) 
     89 33 128 76.7 18.4  
Legend 
CPB: Cardiopulmonary Bypass    
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Table 5: Target and Conduits Vessels 
 
 OPCAB(N=199) CABG-CPB (N=143)  
Conduit Available data Factor Present % Available data Factor Present % P Value 
LIMA 196 183 93.4 138 124 90 0.35 
RIMA 196 12 6.1 138 1 0.7 0.01 
SVG 196 144 73.5 138 131 95 0 
RA 196 49 25 138 16 11.6 0 
GEPA 196 2 1 138 0 0 0.11 
Targets  
LAD 195 191 98 138 136 98.5 0.68 
Diagonals 196 106 54.1 138 75 54.3 0.96 
OM 196 152 77.5 138 117 84.8 0.1 
Ramus 196 27 13.8 138 16 11.6 0.56 
RCA 196 9 4.6 138 18 13 0.01 
PDA 196 123 62.7 138 75 54.3 0.12 
PLWB 196 12 6.1 138 8 5.8 0.9 
Sequential Grafts 196 104 53.1 138 63 45.7 0.24 
TAR 196 51 26 138 6 4.3 0 
 
Legend 
LIMA: Left Internal Mammary Artery               LAD: Left Anterior Descending Artery 
RIMA: Right Internal Mammary Artery            OM: Obtuse marginal artery 
SVG: Saphenous Vein Graft                               RCA: Right Coronary Artery 
RA: Radial Artery                                               PDA: Posterior Descending Artery 
GEPA: Gastroepiploic Artery                             PLWB: Posterolateral wall 
TAR: Total arterial revascularisation 
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Table 6: Postoperative Characteristics (Categorical Variables) 
 OPCAB(N=199) CABG-CPB (N=143)  
 Available 
data 
Factor 
Present 
% Available 
data 
Factor 
Present 
% P Value 
MI 199 5 2.5 142 1 0.7 0.21 
Renal Failure 199 8 4 142 10 7 0.22 
Septicaemia 199 3 1.5 143 8 5.6 0.04 
Pneumonia 199 17 8.5 143 10 7 0.6 
DSW Infection 199 1 0.5 143 6 4.2 0 
CVA 199 2 1 143 8 5.6 0.01 
AF 199 4 2 143 6 4.2 0.24 
Re-exploration 
for Haemorrhage' 
199 2 1 143 4 2.8 0.24 
Death 199 6 3 143 13 9 0.02 
        
Legend 
MI: Myocardial Infarction 
DSW: Deep Sternal Wound Infection 
CVA: Cerebro-Vascular Accident 
AF: Atrial Fibrillation 
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Table 7: Postoperative Characteristics (Continuous Variables) 
 OPCAB (N=199) CABG-CPB (N=143)  
 Available data Min Max Mean ST Dev Available data Min Max Mean ST Dev P Value 
ICU Duration(hours) 166 7 1147 80.7 115.6 116 10 1250 104.1 177 0.1 
MV Duration(hours) 171 0 576 22.38 45.1 126 3 1200 38.3 112.2 0.09 
ICU Blood loss(ml) 170 175 3730 808.5 484.2 125 360 3050 988.2 541.6 0 
RBC Transfusion( Units) 40 1 5 1.72 0.72 69 1 19 2.66 2.64 0.03 
Postoperative Ward Stay 
(Days) 
163 1 40 5.5 4.35 107 1 71 7.4 9 0.01 
Legend 
ICU: Intensive Care Unit 
MV: Mechanical Ventilation 
RBC: Red Blood Cell 
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Table 8: Follow up Characteristics (Categorical Variables) 
 OPCAB(N=199) CABG-CPB(N=143)  
 Available 
data 
Factor 
Present 
% Available 
data 
Factor 
Present 
% P Value 
Angina 
Recurrence 
98 18 18.4 98 20 20.4 0.72 
MACE 98 20 20.4 98 23 23.5 0.61 
Legend 
MACE: Major Adverse Cardiac Event
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                                                                       Table 9: Follow Up Characteristics (Continuous Variables) 
 
 OPCAB (N=199) CABG-CPB(N=143)  
 Available 
data 
Min Max Mean ST Dev Available 
data 
Min Max Mean ST Dev P Value 
Follow up Duration(months) 98 0.25 91 18 22.8 98 1 89 15.3 21.1 0.43 
Angina-Recurrence 
Interval(months) 
18 1 26 8.3 6.89 14 1.5 86 23.4 24.7 0.02 
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Table 10: Comparison of This Study’s Figures with The Literature (Pre-operative Characteristics: Categorical variables) 
 Study Literature  
Variable OPCAB (%) CABG-CPB (%) OPCAB (%) CABG-CPB (%) References 
Age      
Female Gender 25.1 26.6 15.8-23.6 19-20.4 46, 72,74,75 
Previous MI 55.3 58.9 28-69 30-78 78,79,80 
Hypertension 65.1 69 48.8-70 40-56.4 72,73,74,75 
DM 30.4 35.9 18-45.5 14-50.5 76,78,81,82,83 
Renal Failure 3 2.1 3.2-9.7 0.38-8.7 72, 84, 85, 86, 87 
Previous CVA 3.1 2.8 6-9 3-12.7 84, 88,89,90,91,92 
Smoking 75.5 71.8 43-72.9 46.2-78 73,78,88 ,93 
Hyper CHL 58.4 58.9 25.4-91.5 20-84.9 72,73,74,75,82,83 
PVD 18 10 4-27.3 10.2-18 75,79,83,89,94 
COPD 13.8 7.1 3.2-16.6 4.1-19.7 74,77,79,83,85,86 
CAD Family History 69 55.2 25-60 23-57.2 7,27,29,83,95 
Pre-op Aspirin 85.1 85.4 88-100 75-100 88,96 
Pre-op AF 9.2 8 5-25.8 2.7-14.2 74,77,78,83,91,97 
NYHA III/IV 50.8 50.7 2-64.8 1-58.8 41,47,79,98 
CCS III/IV 74.6 81.7 12-72.2 10-72.3 41,47,74,79,82 
Pre-op IABP 9.5 12.8 1-10 4-11.6 46,74,79,80,81,94 
Previous Cardiac 
Operation 
5.6 2.9 0-7.9 0-8 46,72,75,76,77,79,80,83,90,99 
Previous PCI 13.6 7.7 7-30 10-21 34,41,79 
Legend 
- MI: Myocardial Infarction                                      - CCS. Canadian Cardiovascular Society 
- COPD: Chronic Obstructive Pulmonary Disease   - AF: Atrial Fibrillation 
- CVA: Cerebro-Vascular Accident                          - IABP: Intra-aortic balloon pump 
- HyperCHL: Hypercholesterolaemia                       - PCI: Percutaneous Coronary Intervention  
- PVD: Peripheral Vascular Disease                         - NYHA: New York Heart Association 
- CAD: Coronary Artery Disease 
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APPENDIX 
Proforma for Off-Pump Coronary Bypass Grafting Outcomes 
   
 
1) Hosp No:  
2) Age: 
3) Gender: 
4) Weight (kgs): 
5) Height(cm): 
6) BMI: 
                                      Pre-op Data 
7) Risk factors: Yes/No 
a) MI 
b) Hypertension 
c) DM 
d) COPD 
e) Renal failure 
f) Previous CVA 
g) Smoking 
h) Hypercholesterolaemia 
i) Peripheral vascular disease / Carotid disease.  Previous TIA / Stroke 
j) Family History 
8) Pre-op anticoagulant use;  
a) Aspirin                                                      ; Days stopped pre-op:  
b) Warfarin 
 
9) Pre-op AF; Yes/No 
10) Pre-op Mitral regurgitation / other valve pathology 
11) Pre-op medication: 
12) Pre-op NYHA Class: 
13) Pre-op CCS Class: 
14) LVEF; 
a) < 30 
b) 30-49 
c) > 50 
15) Duration of angina: 
16) Investigations; 
a) Hb: 
b) INR: 
c) HIV status 
d) HBV status 
e) Creatinine:  
17) Indication for surgery:  
18) Preop IABP; Yes/No 
19) Previous cardiac operation; Yes/No 
20) Elective / Urgent / Emergency 
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Intra-Op Data 
 
21) CPB: Yes/No 
22) Conversion to ONCAB: Yes/No 
23) Reason for conversion: 
24) CPB duration (minutes): 
25) Aortic Cross-clamp time (minutes) 
26) Intra-aortic balloon pump use: Yes/No 
27) Cell Saver Use: Yes/No 
28) No of Grafts 
29) Graft Distribution: tick appropriate one                   Grafts 
a) LAD                                         A) LIMA 
b) RCA/PDA                                B) Radial 
c) OM                                          C) SVG        
d) D                                              D) RIMA 
e) PLWB 
f) Ramus 
                                        
 
                                                             Post-operative data 
30)  ICU Duration (hours): 
31) Duration of Ventilation (hours) 
32) Blood loss in ICU (ml): 
33) Blood transfusion ICU; 
a) RBCs 
b) FFP 
c) Cryoprecipitate 
d) Platelets 
34) Complications (tick appropriate one) 
a) Post-op MI; Yes/No 
b) Renal failure (Creatinine:>200) 
Any dialysis? Yes/No 
c) Sepsis; 
d) Pneumonia 
e) Deep sternal infection 
f) Superficial Wound infection 
g) Other 
h) Neurological 
i) Stroke 
Other 
j) Re-operation: 
k) Incomplete revascularization: 
l) Atrial fibrillation: Yes/No 
m) Death: 
n) Cause of Death: 
35) Post-op ward stay (days): 
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Follow-up 
 
 
36) Length of Follow-up (months): 
37) Angina recurrence: Yes/No 
38) If (38) Yes: When? 
39) MI recurrence: Yes/No 
40) If (40) yes: When? 
41) Coronary angiography performed – when 
42) Death / Morbidity/ Major Adverse Cardiac Event (MACE); 
 
 
 
 
 
 
